No definition available.
Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder
DOID EFO Endpoint Browser PheWeb
CD2_BENIGN_CONNSOFT_UPPERLIMB
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1832 |
4. Check minimum number of eventsNone |
1832 |
5. Include endpointsNone |
1832 |
6. Filter based on genotype QC (FinnGen only) |
1763 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D21
- Name in latin
- Neoplasma benignum textus connectivi/textus mollis regionis deltoideae
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder
based on the number of shared cases.
Similar with more cases:
- Other benign neoplasms of connective and other soft tissue
- Benign neoplasms
- Neoplasms
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 11643 | 6413 | 5178 |
| Only index persons | 10885 | 6072 | 4813 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.17 | 0.18 | 0.14 |
| Only index persons | 0.21 | 0.22 | 0.18 |
| Median age at first event (years) | |||
| Whole population | 46.94 | 47.68 | 45.95 |
| Only index persons | 46.41 | 47.26 | 45.33 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1763 | 1076 | 687 |
| Unadjusted period prevalence (%) | 0.36 | 0.38 | 0.32 |
| Median age at first event (years) | 50.78 | 49.19 | 53.27 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1832
- Matched controls
- 18320
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
NDR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of wrist or hand
181.5
307.7
655
56
D21.1
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder
13052.3
307.7
1534
7
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
13.2
229.3
229
196
21503
ICD-8 Finland
Other benign neoplasm of muscular and connective tissue, Extremitatis superioris (regione scapulari inclusa)
+∞
199.7
188
*
NDM20
NOMESCO Finland
Excision of synovial ganglion of wrist or hand
12.5
168.6
172
151
R22.3
ICD-10 Finland
Localized swelling, mass and lump, upper limb
11.2
158.7
174
170
M67.4
ICD-10 Finland
Ganglion
5.6
152.3
331
699
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
11.2
130.9
142
136
NDR30
NOMESCO Finland
Complete excision of soft tissue tumour of wrist or hand
128.8
80.7
86
7
NDM99
NOMESCO Finland
Other operation on fascia, ganglion, synovial sheath or bursa of wrist or hand
20.6
78.6
60
30
D21.2
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of lower limb, including hip
24.0
55.7
40
17
2152A
ICD-9 Finland
Other benign neoplasm of connective and other soft tissue, Upper limb, including shoulder[YLÄRAAJAN BENIGNI PEHMYTKUDOSKASVAIN,SIDEKUDOSPERÄI]
+∞
47.1
45
*
9736
FHL
Subcutaneous tumor removal in operating room or anesthesia
8.0
42.2
58
75
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.7
40.5
254
1049
2152X
ICD-9 Finland
Other benign neoplasm of connective and other soft tissue, Upper limb, including shoulder[YLÄRAAJAN BENIGNI PEHMYTKUDOSKASVAIN,TARK MÄÄRITTEL]
+∞
38.7
37
*
S18
ICPC
Laceration/cut
1.9
37.7
950
6674
9491
FHL
Local soft tissue exploration, drainage, or removal
11.5
34.5
36
32
SPAT1153
SPAT
Removal of sutures
1.9
33.4
625
3954
D17.2
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs
4.5
32.5
80
183
WX204
NOMESCO Finland
Axillary plexus blockaced
3.6
30.7
105
305
QCE99
NOMESCO Finland
Other excision or repair of lesion of skin of upper limb
10.1
26.5
30
30
ND1CG
NOMESCO Finland
Wrist and hand extensive MRI examination with high intensity magnet
6.5
25.7
42
66
M19.0
ICD-10 Finland
Primary arthrosis of other joints
2.1
24.1
241
1210
ND2CG
NOMESCO Finland
Extensive MRI of hand
29.6
24.1
32
11
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.7
23.7
522
3401
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.0
23.1
309
1723
WX702
NOMESCO Finland
Supraglottic ventilation device
2.6
23.0
142
578
NBR20
NOMESCO Finland
Intralesional or marginal excision of soft tissue tumour of shoulder or upper arm
23.2
22.6
32
14
2152D
ICD-9 Finland
Other benign neoplasm of connective and other soft tissue, Upper limb, including shoulder[YLÄRAAJAN BENIGNI PEHMYTKUDOSKASVAIN,MUU]
+∞
21.9
21
*
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.2
21.6
194
932
SPAT1301
SPAT
No procedures
1.7
21.3
544
3671
D16.1
ICD-10 Finland
Benign neoplasm: Short bones of upper limb
17.7
21.3
33
19
WX720
NOMESCO Finland
Own respiration
2.6
21.3
124
490
L12
ICPC
Hand/finger symptom/complaint
1.8
21.3
351
2092
NCR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of elbow or forearm
50.6
21.1
25
5
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
3.3
21.1
82
259
N02BE01
ATC
paracetamol; systemic, rectal
2.1
20.9
1653
14877
NDR99
NOMESCO Finland
Other operation for tumour of wrist or hand
111.3
20.6
22
*
ZXA05
NOMESCO Finland
Left side
1.7
20.4
437
2809
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.3
20.1
157
711
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
20.0
302
1748
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
19.9
821
6210
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
4.0
19.5
56
144
WX725
NOMESCO Finland
Noninvasive ventilation
2.4
18.9
130
556
ZXA00
NOMESCO Finland
Right side
1.7
18.4
464
3103
WX704
NOMESCO Finland
Intubation
2.1
18.3
173
848
ACC51
NOMESCO Finland
Release of median nerve
2.2
17.9
168
821
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
4.0
17.8
50
127
M01AH05
ATC
etoricoxib; oral
1.6
17.7
1173
9764
S04
ICPC
Lump/swelling localized
2.0
17.7
223
1214
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
16.8
799
6164
D17.1
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
2.8
16.0
82
304
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.8
15.7
281
1705
WX400
NOMESCO Finland
Inhalation anesthesy
2.6
15.6
92
366
ZXD20
NOMESCO Finland
Day surgery
1.8
15.1
239
1398
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
3.2
14.7
58
185
D18.0
ICD-10 Finland
Haemangioma, any site
3.1
14.6
61
202
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.5
14.4
89
362
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
4.2
14.4
38
92
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
14.1
413
2840
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
2.9
13.6
63
221
ND3CG
NOMESCO Finland
Extensive MRI of fingers
34.3
13.5
17
5
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
13.3
391
2686
N02AX02
ATC
tramadol; systemic, rectal
1.5
13.1
750
5915
M01AE01
ATC
ibuprofen; systemic, rectal
1.8
13.1
1643
15178
N03AX16
ATC
[U] pregabalin
1.6
13.1
405
2816
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
6.0
13.1
23
39
SPAT1263
SPAT
Sampling
1.5
13.1
696
5415
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.1
13.0
127
629
D36.1
ICD-10 Finland
Benign neoplasm: Peripheral nerves and autonomic nervous system
11.0
13.0
24
22
WX203
NOMESCO Finland
Infraclavicular plexus blockade
3.1
13.0
54
178
D21.9
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue, unspecified
10.6
12.7
24
23
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.1
12.7
127
635
M48.0
ICD-10 Finland
Spinal stenosis
1.8
12.6
219
1314
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
5.7
12.4
23
41
QX3HE, ,
SPAT
2.9
12.4
56
194
J01DB01
ATC
cefalexin; oral
1.6
12.2
1477
13337
M03BX02
ATC
tizanidine; oral
1.4
12.0
1127
9670
SPAT1324
SPAT
Screening procedure
1.6
11.9
327
2209
SPAT1260
SPAT
Consultation of another employee
1.6
11.8
286
1872
9473
FHL
Local soft tissue removal or exploration (eg Bursa)
5.2
11.7
24
47
A02BC03
ATC
lansoprazole; oral
1.5
11.7
495
3665
M54.4
ICD-10 Finland
Lumbago with sciatica
1.6
11.7
337
2301
J01FA10
ATC
azithromycin; systemic
1.4
11.6
1003
8458
ND1DG
NOMESCO Finland
Wrist and hand very extensive MRI examination with high intensity magnet
13.7
11.5
19
14
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
2.0
11.4
125
647
ND1BG
NOMESCO Finland
Wrist and hand MRI examination with high intensity magnet
3.7
11.4
36
100
M54.5
ICD-10 Finland
Low back pain
1.4
11.3
657
5159
P01BA02
ATC
hydroxychloroquine; oral
1.9
11.2
151
839
M79.6
ICD-10 Finland
Pain in limb
1.4
11.1
786
6383
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
10.9
622
4862
M01AC06
ATC
meloxicam; systemic, rectal
1.4
10.9
628
4919
N03AX12
ATC
[U] gabapentin; oral
1.6
10.7
287
1922
SFA20
NOMESCO Finland
Two-surface restoration
1.4
10.5
1035
8852
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
2.2
10.5
86
398
C49.19
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder other or unspecified tumor
+∞
10.4
10
*
XA402
NOMESCO Finland
ENMG
2.7
10.2
52
193
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
1.9
10.1
130
712
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
2.8
10.1
48
172
SPAT1285
SPAT
Provision of consultation response
2.1
9.9
92
449
SFA10
NOMESCO Finland
One-surface restoration
1.4
9.7
960
8170
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
2.5
9.7
60
246
L08
ICPC
Shoulder symptom/complaint
1.5
9.7
407
2997
WX120
NOMESCO Finland
Intravenous local anesthesy of arm
3.4
9.6
34
102
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
9.5
191
1191
M01AB05
ATC
diclofenac; systemic, rectal
1.4
9.4
1159
10194
WZA90
NOMESCO Finland
Other medical or dental certificate
1.5
9.3
392
2886
SPAT1310
SPAT
Counselling related to known health issue
1.4
9.3
497
3822
9474
FHL
Soft tissue tumor removal (subcutaneous tumor 9736 skin tumor 9733)
13.7
9.2
15
11
H02AB06
ATC
prednisolone; systemic
1.4
9.1
804
6701
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.4
9.1
62
266
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
9.1
1265
11312
WX110
NOMESCO Finland
Infiltration anesthesia
1.4
9.0
1257
11231
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
3.4
8.9
31
92
N04BC04
ATC
ropinirole; oral
4.4
8.9
22
51
NDM10
NOMESCO Finland
Palmar fasciotomy of hand
2.8
8.7
41
146
M79.7
ICD-10 Finland
Fibromyalgia
2.2
8.6
71
330
NBF25
NOMESCO Finland
Operation for humeroscapular osteochondritis, arthroscopic
2.6
8.6
47
181
NBR30
NOMESCO Finland
Extensive or radical excision of soft tissue tumour of shoulder or upper arm
90.5
8.4
9
*
NHM20
NOMESCO Finland
Excision of synovial ganglion of ankle or foot
3.6
8.4
27
76
2152C
ICD-9 Finland
Other benign neoplasm of connective and other soft tissue, Upper limb, including shoulder[YLÄRAAJAN BENIGNI PEHMYTKUDOSKASVAIN,HERMOPERÄINEN]
+∞
8.3
8
*
N02BF01
ATC
gabapentin; oral
1.6
8.3
188
1209
SPAT1202
SPAT
Intra-articular injection
2.5
8.3
52
215
NDU20
NOMESCO Finland
Removal of internal fixation device from wrist or hand
2.8
8.2
39
140
A02BC05
ATC
esomeprazole; systemic
1.3
8.2
681
5600
M72.0
ICD-10 Finland
Palmar fascial fibromatosis [Dupuytren]
2.3
8.1
57
248
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.7
8.0
137
818
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.4
8.0
353
2615
A02BC01
ATC
omeprazole; systemic
1.4
7.9
430
3300
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
7.9
410
3122
NB1DG
NOMESCO Finland
Shoulder and humerus very extensive MRI examination with high intensity magnet
3.7
7.7
24
66
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.6
7.7
208
1392
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
2.0
7.7
85
442
TQW40, ,
SPAT
1.6
7.7
179
1157
M25.5
ICD-10 Finland
Pain in joint
1.3
7.7
583
4715
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
7.7
187
1222
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.7
7.6
143
875
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
7.6
615
5019
M01AH01
ATC
celecoxib; oral
1.5
7.6
285
2043
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
7.6
1146
10212
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
7.6
683
5664
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.7
7.5
146
902
WZC00
NOMESCO Finland
Treatment plan or consultation
1.3
7.5
609
4974
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
7.4
793
6729
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
2.1
7.3
65
312
X58
ICD-10 Finland
Exposure to other specified factors
1.5
7.3
255
1802
R06AX27
ATC
desloratadine; oral
1.4
7.3
485
3839
M65.3
ICD-10 Finland
Trigger finger
1.9
7.3
90
487
K02.1
ICD-10 Finland
Caries of dentine
1.3
7.3
1001
8785
J01DA01
ATC
[U] cefalexin
1.3
7.3
1043
9205
UJF32
NOMESCO Finland
Coloscopy
1.4
7.3
414
3199
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.8
7.2
112
650
NHM99
NOMESCO Finland
Other operation on fascia, ganglion, synovial sheath or bursa of ankle or foot
4.3
7.2
18
42
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
1.9
7.2
90
490
NC1DG
NOMESCO Finland
Elbow and forearm very extensive MRI examination with high intensity magnet
20.1
7.1
10
5
D16.0
ICD-10 Finland
Benign neoplasm: Scapula and long bones of upper limb
20.1
7.1
10
5
NDK99
NOMESCO Finland
Other operation on bone of hand or wrist
10.1
7.0
13
13
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
1.9
7.0
84
450
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
3.4
7.0
24
71
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.4
7.0
419
3264
M65.8
ICD-10 Finland
Other synovitis and tenosynovitis
2.4
6.9
47
202
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
1.8
6.9
94
525
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.8
6.9
103
593
R51.80
ICD-10 Finland
Headache
1.5
6.7
260
1874
M54.2
ICD-10 Finland
Cervicalgia
1.6
6.7
143
905
G56.2
ICD-10 Finland
Lesion of ulnar nerve
2.1
6.7
63
310
D21.6
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of trunk, unspecified
22.6
6.7
9
*
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
6.7
633
5265
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.6
6.7
159
1035
LX2A3, ,
SPAT
2.1
6.6
60
291
NBL05
NOMESCO Finland
Arthroscopic suture or reinsertation of rotator cuff of shoulder
2.8
6.6
31
111
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
12.3
6.6
11
9
WX290
NOMESCO Finland
Other blockage of nerve
1.3
6.6
807
6942
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.5
6.5
235
1672
M70.6
ICD-10 Finland
Trochanteric bursitis
1.5
6.5
225
1589
J02AC01
ATC
fluconazole; systemic
1.3
6.5
656
5501
D48.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Peripheral nerves and autonomic nervous system
14.4
6.4
10
7
-1, ,
NOMESCO Finland
1.3
6.4
533
4352
T14.0
ICD-10 Finland
Superficial injury of unspecified body region
2.9
6.3
28
97
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
2.2
6.3
48
217
ND1AA
NOMESCO Finland
Wrist X-ray examination
1.7
6.3
114
693
ND3CM
NOMESCO Finland
Extensive MRI of fingers (more than 1.5 T)
+∞
6.3
6
*
ND3BG
NOMESCO Finland
MRI of fingers
26.8
6.2
8
*
WX402
NOMESCO Finland
General anaesthesia
1.4
6.2
371
2880
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
1.8
6.2
86
484
ND2AA, ,
SPAT
1.7
6.2
99
581
J01AA02
ATC
doxycycline; systemic
1.3
6.2
1342
12373
NDF25
NOMESCO Finland
Operation for osteochondritis of joint of wrist, arthroscopic
4.0
6.2
17
43
G56.4
ICD-10 Finland
Causalgia
5.8
6.1
16
28
A07EC01
ATC
sulfasalazine; oral, rectal
1.6
6.1
128
807
D17.9
ICD-10 Finland
Benign lipomatous neoplasm, unspecified
2.9
6.1
28
99
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
6.0
377
2946
ENC40
NOMESCO Finland
Uvulopalatopharyngoplasty
3.2
6.0
23
73
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
2.0
6.0
64
330
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Hand Surgery
40 [38004480]
40 [38004480]
1.2e+00
2.8e+00
3.9e+00
—
4.7e+00
4.2e+00
1.8e+00
cases:8.35%
controls:2.66%
cases:13.39%
controls:0.91%
cases:5.47%
controls:0.12%
—
—
cases:14.41%
controls:0.16%
cases:32.06%
controls:0.67%
cases:15.04%
controls:2.84%
139
439
1526
16077
223
150
1442
16366
91
20
1574
16496
—
240
26
1425
16469
527
109
1117
16114
227
419
1282
14311
Ganglion
M67.4 [45582222]
M67.4 [45582222]
1.6e+00
3.8e+00
—
—
3.5e+00
3.1e+00
1.3e+00
cases:2.16%
controls:0.45%
cases:6.13%
controls:0.14%
—
—
—
—
cases:1.02%
controls:0.03%
cases:3.41%
controls:0.17%
cases:2.45%
controls:0.71%
36
75
1629
16441
102
23
1563
16493
—
—
17
5
1648
16490
56
27
1588
16196
37
104
1472
14626
Orthopedic Surgery
20 [38004465]
20 [38004465]
6.4e-01
1.1e+00
1.3e+00
5.9e+00
1.5e+00
1.2e+00
7.1e-01
cases:19.52%
controls:11.35%
cases:11.53%
controls:4.30%
cases:2.58%
controls:0.74%
cases:11.71%
controls:0.04%
cases:3.66%
controls:0.81%
cases:13.69%
controls:4.65%
cases:24.78%
controls:13.88%
325
1874
1340
14642
192
711
1473
15805
43
123
1622
16393
195
6
1470
16510
61
133
1604
16362
225
755
1419
15468
374
2045
1135
12685
Localized swelling, mass and lump, upper limb
R22.3 [45548956]
R22.3 [45548956]
2.4e+00
5.0e+00
—
—
—
2.9e+00
1.8e+00
cases:1.02%
controls:0.10%
cases:5.23%
controls:0.04%
—
—
—
—
—
—
cases:0.79%
controls:0.04%
cases:0.86%
controls:0.14%
17
16
1648
16500
87
6
1578
16510
—
—
—
13
7
1631
16216
13
21
1496
14709
Outpatient Visit
OP [9202]
OP [9202]
3.2e-01
5.9e-01
7.7e-01
6.2e+00
1.2e+00
9.1e-01
5.1e-01
cases:69.43%
controls:62.16%
cases:55.50%
controls:40.95%
cases:17.06%
controls:8.69%
cases:68.41%
controls:0.44%
cases:24.38%
controls:8.92%
cases:63.02%
controls:40.74%
cases:80.38%
controls:71.19%
1156
10266
509
6250
924
6763
741
9753
284
1435
1381
15081
1139
72
526
16444
406
1471
1259
15024
1036
6609
608
9614
1213
10487
296
4243
Excision of synovial ganglion of wrist or hand
NDM20 [2001307725]
NDM20 [2001307725]
1.7e+00
2.5e+00
—
1.0e+50
1.0e+50
4.1e+00
2.0e+00
cases:0.78%
controls:0.14%
cases:0.42%
controls:0.04%
—
—
cases:2.58%
controls:0.00%
cases:0.48%
controls:0.00%
cases:2.55%
controls:0.04%
cases:1.06%
controls:0.14%
13
23
1652
16493
7
6
1658
16510
—
43
0
1622
16516
8
0
1657
16495
42
7
1602
16216
16
21
1493
14709
Carpal tunnel syndrome
G56.0 [45566891]
G56.0 [45566891]
9.3e-01
1.8e+00
2.6e+00
—
2.4e+00
1.7e+00
8.3e-01
cases:3.42%
controls:1.38%
cases:2.46%
controls:0.42%
cases:0.72%
controls:0.05%
—
—
cases:0.66%
controls:0.06%
cases:2.43%
controls:0.43%
cases:3.78%
controls:1.69%
57
228
1608
16288
41
69
1624
16447
12
9
1653
16507
—
11
10
1654
16485
40
70
1604
16153
57
249
1452
14481
Removal of sutures
SPAT1153 [2001700254]
SPAT1153 [2001700254]
4.7e-01
7.6e-01
2.2e+00
—
3.8e+00
1.9e+00
8.4e-01
cases:5.53%
controls:3.54%
cases:2.10%
controls:0.99%
cases:1.14%
controls:0.13%
—
—
cases:4.02%
controls:0.09%
cases:5.60%
controls:0.88%
cases:8.75%
controls:3.96%
92
585
1573
15931
35
164
1630
16352
19
21
1646
16495
—
67
15
1598
16480
92
143
1552
16080
132
583
1377
14147
Plastic And Reconstructive Surgery
24 [38004467]
24 [38004467]
7.5e-01
1.4e+00
2.2e+00
1.0e+50
2.4e+00
1.7e+00
1.3e+00
cases:4.62%
controls:2.24%
cases:3.42%
controls:0.89%
cases:1.26%
controls:0.14%
cases:4.14%
controls:0.00%
cases:1.20%
controls:0.11%
cases:4.62%
controls:0.84%
cases:7.89%
controls:2.30%
77
370
1588
16146
57
147
1608
16369
21
23
1644
16493
69
0
1596
16516
20
18
1645
16477
76
137
1568
16086
119
339
1390
14391
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
D48.1 [45566694]
D48.1 [45566694]
1.7e+00
4.7e+00
—
1.0e+50
—
—
2.9e+00
cases:0.60%
controls:0.11%
cases:3.12%
controls:0.03%
—
—
cases:0.72%
controls:0.00%
—
—
—
—
cases:1.39%
controls:0.08%
10
18
1655
16498
52
5
1613
16511
—
12
0
1653
16516
—
—
21
12
1488
14718
ibuprofen
R02AX02 [1588667]
R02AX02 [1588667]
4.1e-01
5.7e-01
7.9e-01
4.3e+00
1.5e+00
8.8e-01
5.8e-01
cases:42.70%
controls:33.07%
cases:23.96%
controls:15.19%
cases:4.44%
controls:2.06%
cases:4.08%
controls:0.06%
cases:9.07%
controls:2.07%
cases:30.41%
controls:15.29%
cases:48.84%
controls:34.94%
711
5462
954
11054
399
2509
1266
14007
74
340
1591
16176
68
10
1597
16506
151
342
1514
16153
500
2481
1144
13742
737
5147
772
9583
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
M01AE01 [21603967]
4.1e-01
5.7e-01
7.9e-01
4.3e+00
1.5e+00
8.8e-01
5.8e-01
cases:42.70%
controls:33.07%
cases:23.96%
controls:15.19%
cases:4.44%
controls:2.06%
cases:4.08%
controls:0.06%
cases:9.07%
controls:2.07%
cases:30.41%
controls:15.29%
cases:48.84%
controls:34.94%
711
5462
954
11054
399
2509
1266
14007
74
340
1591
16176
68
10
1597
16506
151
342
1514
16153
500
2481
1144
13742
737
5147
772
9583
Localized swelling, mass and lump, unspecified
R22.9 [45577788]
R22.9 [45577788]
8.3e-01
2.8e+00
3.0e+00
—
—
1.6e+00
8.4e-01
cases:1.20%
controls:0.53%
cases:2.88%
controls:0.19%
cases:0.72%
controls:0.04%
—
—
—
—
cases:0.91%
controls:0.19%
cases:1.92%
controls:0.84%
20
87
1645
16429
48
31
1617
16485
12
6
1653
16510
—
—
15
31
1629
16192
29
123
1480
14607
Palmar fascial fibromatosis [Dupuytren]
M72.0 [45543681]
M72.0 [45543681]
7.6e-01
2.2e+00
—
1.0e+50
2.5e+00
2.2e+00
1.0e+00
cases:0.66%
controls:0.31%
cases:1.08%
controls:0.12%
—
—
cases:0.54%
controls:0.00%
cases:0.36%
controls:0.03%
cases:0.73%
controls:0.08%
cases:0.93%
controls:0.33%
11
51
1654
16465
18
19
1647
16497
—
9
0
1656
16516
6
5
1659
16490
12
13
1632
16210
14
49
1495
14681
Laceration/cut
S18 [2002000983]
S18 [2002000983]
3.0e-01
8.6e-01
1.7e+00
—
3.3e+00
1.3e+00
6.5e-01
cases:6.49%
controls:4.88%
cases:3.84%
controls:1.67%
cases:1.20%
controls:0.23%
—
—
cases:4.38%
controls:0.18%
cases:7.30%
controls:2.02%
cases:12.59%
controls:6.97%
108
806
1557
15710
64
276
1601
16240
20
38
1645
16478
—
73
29
1592
16466
120
327
1524
15896
190
1027
1319
13703
Excision of other lesion extending through all layers of skin in upper limb
QCE10 [2001309914]
QCE10 [2001309914]
1.9e+00
—
—
1.0e+50
—
4.3e+00
1.4e+00
cases:0.72%
controls:0.11%
—
—
—
—
cases:4.98%
controls:0.00%
—
—
cases:2.25%
controls:0.03%
cases:0.73%
controls:0.18%
12
18
1653
16498
—
—
83
0
1582
16516
—
37
5
1607
16218
11
27
1498
14703
cefalexin; oral
J01DB01 [21602870]
J01DB01 [21602870]
4.9e-01
4.4e-01
1.1e+00
2.6e+00
1.6e+00
6.8e-01
4.0e-01
cases:36.58%
controls:26.10%
cases:12.61%
controls:8.50%
cases:2.58%
controls:0.90%
cases:0.48%
controls:0.04%
cases:4.38%
controls:0.89%
cases:14.66%
controls:8.00%
cases:34.00%
controls:25.63%
609
4310
1056
12206
210
1404
1455
15112
43
149
1622
16367
8
6
1657
16510
73
146
1592
16349
241
1298
1403
14925
513
3775
996
10955
One hour or less
ZXE00 [2001311394]
ZXE00 [2001311394]
-2.1e-03
6.4e-01
1.6e+00
—
2.6e+00
1.7e+00
7.3e-01
cases:4.92%
controls:4.93%
cases:2.46%
controls:1.31%
cases:0.66%
controls:0.14%
—
—
cases:1.56%
controls:0.12%
cases:6.08%
controls:1.17%
cases:7.55%
controls:3.78%
82
815
1583
15701
41
216
1624
16300
11
23
1654
16493
—
26
19
1639
16476
100
189
1544
16034
114
557
1395
14173
Hand and fingers X-ray examination
ND2AA [2001307607]
ND2AA [2001307607]
7.9e-01
2.4e+00
—
1.0e+50
—
2.5e+00
1.6e+00
cases:1.74%
controls:0.80%
cases:2.34%
controls:0.22%
—
—
cases:2.40%
controls:0.00%
—
—
cases:2.31%
controls:0.20%
cases:3.31%
controls:0.72%
29
132
1636
16384
39
37
1626
16479
—
40
0
1625
16516
—
38
32
1606
16191
50
106
1459
14624
Physical Medicine And Rehabilitation
25 [38004468]
25 [38004468]
5.9e-01
8.3e-01
8.5e-01
2.5e+00
1.2e+00
1.2e+00
8.7e-01
cases:9.79%
controls:5.67%
cases:4.50%
controls:2.02%
cases:0.90%
controls:0.39%
cases:0.36%
controls:0.03%
cases:1.32%
controls:0.41%
cases:6.87%
controls:2.19%
cases:14.31%
controls:6.54%
163
937
1502
15579
75
333
1590
16183
15
64
1650
16452
6
5
1659
16511
22
67
1643
16428
113
355
1531
15868
216
963
1293
13767
Haemangioma, any site
D18.0 [45586089]
D18.0 [45586089]
5.0e-01
2.7e+00
—
—
—
2.9e+00
1.5e+00
cases:0.30%
controls:0.18%
cases:0.54%
controls:0.04%
—
—
—
—
—
—
cases:0.79%
controls:0.04%
cases:0.80%
controls:0.18%
5
30
1660
16486
9
6
1656
16510
—
—
—
13
7
1631
16216
12
26
1497
14704
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
13317-3 [3019902]
-2.6e-02
4.9e-01
2.0e+00
—
2.2e+00
1.5e+00
1.1e+00
cases:1.02%
controls:1.05%
cases:0.66%
controls:0.41%
cases:0.36%
controls:0.05%
—
—
cases:0.42%
controls:0.05%
cases:1.89%
controls:0.41%
cases:3.25%
controls:1.09%
17
173
1648
16343
11
67
1654
16449
6
8
1659
16508
—
7
8
1658
16487
31
67
1613
16156
49
161
1460
14569
Hand/finger symptom/complaint
L12 [2002000636]
L12 [2002000636]
7.4e-01
1.5e+00
2.3e+00
—
—
1.6e+00
7.0e-01
cases:2.76%
controls:1.33%
cases:2.16%
controls:0.51%
cases:0.54%
controls:0.05%
—
—
—
—
cases:1.95%
controls:0.41%
cases:3.71%
controls:1.87%
46
220
1619
16296
36
84
1629
16432
9
9
1656
16507
—
—
32
67
1612
16156
56
276
1453
14454
codeine and paracetamol
N02AJ06 [1123647]
N02AJ06 [1123647]
3.6e-01
5.3e-01
6.2e-01
3.6e+00
8.9e-01
7.1e-01
5.7e-01
cases:15.62%
controls:11.45%
cases:7.27%
controls:4.40%
cases:1.62%
controls:0.88%
cases:1.32%
controls:0.04%
cases:2.10%
controls:0.87%
cases:8.70%
controls:4.49%
cases:20.74%
controls:12.84%
260
1891
1405
14625
121
727
1544
15789
27
145
1638
16371
22
6
1643
16510
35
144
1630
16351
143
729
1501
15494
313
1892
1196
12838
General Surgery
2 [38004447]
2 [38004447]
4.5e-01
7.8e-01
1.5e+00
—
2.3e+00
1.0e+00
4.5e-01
cases:24.50%
controls:17.12%
cases:10.51%
controls:5.12%
cases:3.18%
controls:0.71%
—
—
cases:5.89%
controls:0.64%
cases:12.77%
controls:5.04%
cases:20.74%
controls:14.35%
408
2828
1257
13688
175
846
1490
15670
53
117
1612
16399
—
98
106
1567
16389
210
818
1434
15405
313
2114
1196
12616
Right side
ZXA00 [2001311346]
ZXA00 [2001311346]
5.0e-01
3.6e-01
1.4e+00
1.0e+50
3.5e+00
1.9e+00
5.0e-01
cases:4.68%
controls:2.91%
cases:1.02%
controls:0.71%
cases:0.30%
controls:0.07%
cases:2.28%
controls:0.00%
cases:1.56%
controls:0.05%
cases:4.38%
controls:0.69%
cases:4.24%
controls:2.61%
78
480
1587
16036
17
118
1648
16398
5
12
1660
16504
38
0
1627
16516
26
8
1639
16487
72
112
1572
16111
64
384
1445
14346
Day surgery
ZXD20 [2001311388]
ZXD20 [2001311388]
5.3e-01
9.5e-01
—
1.0e+50
3.1e+00
2.6e+00
7.1e-01
cases:1.62%
controls:0.96%
cases:0.78%
controls:0.30%
—
—
cases:2.82%
controls:0.00%
cases:0.90%
controls:0.04%
cases:2.25%
controls:0.18%
cases:1.92%
controls:0.96%
27
158
1638
16358
13
50
1652
16466
—
47
0
1618
16516
15
7
1650
16488
37
29
1607
16194
29
141
1480
14589
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
N02BE01 [21604344]
3.6e-01
3.4e-01
4.6e-01
3.3e+00
9.8e-01
6.6e-01
4.4e-01
cases:32.97%
controls:25.47%
cases:17.78%
controls:13.30%
cases:3.42%
controls:2.18%
cases:2.16%
controls:0.08%
cases:5.83%
controls:2.27%
cases:23.60%
controls:13.78%
cases:43.54%
controls:33.11%
549
4206
1116
12310
296
2197
1369
14319
57
360
1608
16156
36
13
1629
16503
97
374
1568
16121
388
2236
1256
13987
657
4877
852
9853
Incomplete excision of soft tissue tumour of wrist or hand
NDR20 [2001307741]
NDR20 [2001307741]
2.5e+00
—
1.0e+50
1.0e+50
1.0e+50
—
3.7e+00
cases:0.84%
controls:0.07%
—
—
cases:1.20%
controls:0.00%
cases:13.03%
controls:0.00%
cases:6.79%
controls:0.00%
—
—
cases:3.31%
controls:0.09%
14
12
1651
16504
—
20
0
1645
16516
217
0
1448
16516
113
0
1552
16495
—
50
13
1459
14717
Other seropositive rheumatoid arthritis
M05.8 [45538634]
M05.8 [45538634]
1.1e+00
1.3e+00
1.5e+00
—
1.1e+00
1.2e+00
1.1e+00
cases:2.22%
controls:0.76%
cases:2.04%
controls:0.59%
cases:0.72%
controls:0.17%
—
—
cases:0.66%
controls:0.21%
cases:2.07%
controls:0.66%
cases:2.92%
controls:0.94%
37
126
1628
16390
34
98
1631
16418
12
28
1653
16488
—
11
35
1654
16460
34
107
1610
16116
44
139
1465
14591
Axillary plexus blockaced
WX204 [2001310780]
WX204 [2001310780]
1.2e+00
—
—
1.0e+50
—
3.8e+00
1.9e+00
cases:0.66%
controls:0.21%
—
—
—
—
cases:0.54%
controls:0.00%
—
—
cases:2.25%
controls:0.05%
cases:1.19%
controls:0.18%
11
34
1654
16482
—
—
9
0
1656
16516
—
37
8
1607
16215
18
26
1491
14704
Pathology report gross observation
24419-4 [3002256]
24419-4 [3002256]
-1.3e-01
6.2e-01
2.7e+00
1.0e+50
—
2.2e+00
6.9e-01
cases:1.20%
controls:1.36%
cases:1.02%
controls:0.55%
cases:0.60%
controls:0.04%
cases:0.96%
controls:0.00%
—
—
cases:3.41%
controls:0.39%
cases:2.98%
controls:1.52%
20
225
1645
16291
17
91
1648
16425
10
7
1655
16509
16
0
1649
16516
—
56
64
1588
16159
45
224
1464
14506
Respiratory and circulatory monitoring
WX700 [2001310817]
WX700 [2001310817]
3.6e-01
7.0e-01
—
1.0e+50
2.7e+00
2.0e+00
7.7e-01
cases:2.28%
controls:1.61%
cases:0.96%
controls:0.48%
—
—
cases:0.54%
controls:0.00%
cases:0.90%
controls:0.06%
cases:2.37%
controls:0.33%
cases:3.51%
controls:1.66%
38
266
1627
16250
16
79
1649
16437
—
9
0
1656
16516
15
10
1650
16485
39
53
1605
16170
53
244
1456
14486
Inpatient Hospital
21 [8717]
21 [8717]
3.0e-01
1.2e-01
2.1e-01
4.3e+00
5.4e-01
4.7e-01
2.6e-01
cases:33.69%
controls:27.34%
cases:9.55%
controls:8.56%
cases:1.44%
controls:1.17%
cases:3.06%
controls:0.04%
cases:1.98%
controls:1.17%
cases:12.53%
controls:8.19%
cases:27.04%
controls:22.22%
561
4516
1104
12000
159
1413
1506
15103
24
193
1641
16323
51
7
1614
16509
33
193
1632
16302
206
1328
1438
14895
408
3273
1101
11457
CR(E)ST syndrome
M34.1 [45582129]
M34.1 [45582129]
—
—
—
—
—
2.5e+00
2.9e+00
—
—
—
—
—
—
—
—
—
—
cases:0.36%
controls:0.03%
cases:0.60%
controls:0.03%
—
—
—
—
—
6
5
1638
16218
9
5
1500
14725
Left side
ZXA05 [2001311347]
ZXA05 [2001311347]
1.3e-01
7.4e-01
1.6e+00
—
2.8e+00
1.7e+00
6.0e-01
cases:2.82%
controls:2.48%
cases:1.44%
controls:0.70%
cases:0.30%
controls:0.06%
—
—
cases:1.02%
controls:0.06%
cases:3.22%
controls:0.62%
cases:3.98%
controls:2.22%
47
410
1618
16106
24
115
1641
16401
5
10
1660
16506
—
17
10
1648
16485
53
101
1591
16122
60
327
1449
14403
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
T81.4 [45575538]
7.3e-01
5.3e-01
1.8e+00
—
2.2e+00
1.3e+00
7.4e-01
cases:1.80%
controls:0.88%
cases:0.48%
controls:0.28%
cases:0.30%
controls:0.05%
—
—
cases:0.48%
controls:0.05%
cases:0.97%
controls:0.27%
cases:1.79%
controls:0.86%
30
145
1635
16371
8
47
1657
16469
5
8
1660
16508
—
8
9
1657
16486
16
43
1628
16180
27
127
1482
14603
Infraclavicular plexus blockade
WX203 [2001310779]
WX203 [2001310779]
—
2.2e+00
—
—
—
2.7e+00
1.4e+00
—
—
cases:0.42%
controls:0.05%
—
—
—
—
—
—
cases:0.91%
controls:0.06%
cases:0.60%
controls:0.15%
—
7
8
1658
16508
—
—
—
15
10
1629
16213
9
22
1500
14708
Primary arthrosis of other joints
M19.0 [45601353]
M19.0 [45601353]
9.8e-01
1.5e+00
—
—
—
1.3e+00
1.1e+00
cases:2.28%
controls:0.87%
cases:1.56%
controls:0.36%
—
—
—
—
—
—
cases:1.22%
controls:0.35%
cases:3.11%
controls:1.03%
38
144
1627
16372
26
60
1639
16456
—
—
—
20
56
1624
16167
47
151
1462
14579
Release of median nerve
ACC51 [2001300642]
ACC51 [2001300642]
5.7e-01
1.5e+00
—
1.0e+50
—
2.3e+00
1.0e+00
cases:1.08%
controls:0.61%
cases:0.72%
controls:0.17%
—
—
cases:0.48%
controls:0.00%
—
—
cases:1.34%
controls:0.13%
cases:2.19%
controls:0.79%
18
101
1647
16415
12
28
1653
16488
—
8
0
1657
16516
—
22
21
1622
16202
33
117
1476
14613
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
5.8e-02
1.5e-01
4.3e-01
3.4e+00
5.4e-01
1.7e-01
1.1e-01
cases:51.77%
controls:50.31%
cases:46.67%
controls:43.02%
cases:23.90%
controls:16.98%
cases:22.16%
controls:0.95%
cases:25.71%
controls:16.85%
cases:49.94%
controls:45.79%
cases:68.79%
controls:66.38%
862
8310
803
8206
777
7106
888
9410
398
2805
1267
13711
369
157
1296
16359
428
2779
1237
13716
821
7429
823
8794
1038
9778
471
4952
Tissue Pathology biopsy report
66121-5 [40768804]
66121-5 [40768804]
2.0e-01
4.4e-01
1.6e+00
—
1.7e+00
1.1e+00
2.5e-01
cases:6.37%
controls:5.26%
cases:3.30%
controls:2.16%
cases:1.20%
controls:0.25%
—
—
cases:1.50%
controls:0.28%
cases:5.11%
controls:1.84%
cases:8.35%
controls:6.65%
106
868
1559
15648
55
356
1610
16160
20
42
1645
16474
—
25
46
1640
16449
84
299
1560
15924
126
979
1383
13751
etoricoxib; oral
M01AH05 [21603996]
M01AH05 [21603996]
4.5e-01
4.5e-01
7.5e-03
2.3e+00
5.0e-01
5.2e-01
4.4e-01
cases:18.20%
controls:12.46%
cases:7.87%
controls:5.15%
cases:0.78%
controls:0.78%
cases:0.36%
controls:0.04%
cases:1.20%
controls:0.73%
cases:8.15%
controls:5.01%
cases:22.00%
controls:15.39%
303
2058
1362
14458
131
850
1534
15666
13
128
1652
16388
6
6
1659
16510
20
121
1645
16374
134
813
1510
15410
332
2267
1177
12463
Localized swelling, mass and lump, trunk
R22.2 [45602014]
R22.2 [45602014]
2.9e-01
2.2e+00
—
—
—
1.9e+00
6.2e-01
cases:0.30%
controls:0.22%
cases:0.66%
controls:0.07%
—
—
—
—
—
—
cases:0.43%
controls:0.06%
cases:0.46%
controls:0.25%
5
37
1660
16479
11
12
1654
16504
—
—
—
7
10
1637
16213
7
37
1502
14693
Scheduled procedure
ZXD10 [2001311387]
ZXD10 [2001311387]
7.7e-02
3.5e-01
1.1e+00
—
2.1e+00
1.2e+00
6.1e-01
cases:5.65%
controls:5.25%
cases:2.10%
controls:1.49%
cases:0.36%
controls:0.12%
—
—
cases:1.32%
controls:0.16%
cases:3.89%
controls:1.18%
cases:6.23%
controls:3.48%
94
867
1571
15649
35
246
1630
16270
6
19
1659
16497
—
22
26
1643
16469
64
192
1580
16031
94
512
1415
14218
Emergency Room Visit
ER [9203]
ER [9203]
2.8e-01
1.2e-01
1.9e-01
2.7e+00
7.1e-01
2.5e-01
3.1e-01
cases:33.87%
controls:27.83%
cases:10.99%
controls:9.89%
cases:1.38%
controls:1.14%
cases:0.60%
controls:0.04%
cases:2.28%
controls:1.13%
cases:11.50%
controls:9.17%
cases:32.94%
controls:26.40%
564
4597
1101
11919
183
1633
1482
14883
23
189
1642
16327
10
7
1655
16509
38
187
1627
16308
189
1487
1455
14736
497
3889
1012
10841
ENMG
XA402 [2001300405]
XA402 [2001300405]
6.0e-01
2.3e+00
—
—
—
—
1.6e+00
cases:0.42%
controls:0.23%
cases:0.48%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.93%
controls:0.18%
7
38
1658
16478
8
8
1657
16508
—
—
—
—
14
27
1495
14703
Cathetrisation of vein
TPH04 [2001309597]
TPH04 [2001309597]
1.7e-01
5.6e-01
—
1.0e+50
2.1e+00
1.1e+00
6.8e-01
cases:2.46%
controls:2.09%
cases:1.32%
controls:0.76%
—
—
cases:0.36%
controls:0.00%
cases:1.02%
controls:0.13%
cases:2.13%
controls:0.69%
cases:4.71%
controls:2.44%
41
345
1624
16171
22
125
1643
16391
—
6
0
1659
16516
17
21
1648
16474
35
112
1609
16111
71
360
1438
14370
Discission of sheath of tendon of wrist or hand
NDM40 [2001307726]
NDM40 [2001307726]
7.2e-01
-1.0e+50
—
—
—
1.9e+00
2.0e+00
cases:0.42%
controls:0.21%
cases:0.00%
controls:0.05%
—
—
—
—
—
—
cases:0.55%
controls:0.08%
cases:1.79%
controls:0.25%
7
34
1658
16482
0
9
1665
16507
—
—
—
9
13
1635
16210
27
37
1482
14693
More than one and less than three hours
ZXE10 [2001311401]
ZXE10 [2001311401]
1.8e-01
4.2e-01
1.0e+00
1.0e+50
2.2e+00
1.2e+00
5.4e-01
cases:5.77%
controls:4.86%
cases:1.74%
controls:1.16%
cases:0.30%
controls:0.11%
cases:0.60%
controls:0.00%
cases:0.90%
controls:0.10%
cases:3.16%
controls:0.99%
cases:5.77%
controls:3.44%
96
803
1569
15713
29
191
1636
16325
5
18
1660
16498
10
0
1655
16516
15
17
1650
16478
52
161
1592
16062
87
506
1422
14224
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
50949-7 [3029937]
4.9e-01
7.3e-01
1.2e+00
—
4.1e-01
7.8e-01
5.8e-01
cases:5.71%
controls:3.58%
cases:3.78%
controls:1.86%
cases:0.72%
controls:0.21%
—
—
cases:0.30%
controls:0.20%
cases:4.26%
controls:2.00%
cases:10.60%
controls:6.20%
95
591
1570
15925
63
307
1602
16209
12
35
1653
16481
—
5
33
1660
16462
70
324
1574
15899
160
913
1349
13817
Oncology Clinic/Center
261QX0200X [38004268]
261QX0200X [38004268]
2.6e-01
1.9e-01
—
—
3.0e+00
8.0e-01
3.8e-01
cases:4.44%
controls:3.46%
cases:1.32%
controls:1.09%
—
—
—
—
cases:0.96%
controls:0.05%
cases:2.07%
controls:0.94%
cases:5.04%
controls:3.50%
74
571
1591
15945
22
180
1643
16336
—
—
16
8
1649
16487
34
153
1610
16070
76
515
1433
14215
Trigger finger
M65.3 [45538828]
M65.3 [45538828]
4.1e-01
1.4e+00
—
1.0e+50
—
1.3e+00
1.1e+00
cases:0.48%
controls:0.32%
cases:0.60%
controls:0.15%
—
—
cases:0.42%
controls:0.00%
—
—
cases:0.67%
controls:0.18%
cases:1.59%
controls:0.55%
8
53
1657
16463
10
24
1655
16492
—
7
0
1658
16516
—
11
30
1633
16193
24
81
1485
14649
Operation for humeroscapular osteochondritis, arthroscopic
NBF25 [2001307294]
NBF25 [2001307294]
1.8e+00
—
—
—
—
-1.0e+50
1.9e+00
cases:0.54%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.04%
cases:0.73%
controls:0.11%
9
15
1656
16501
—
—
—
—
0
6
1644
16217
11
16
1498
14714
Excision of other lesion extending through all layers of skin of trunk
QBE10 [2001309853]
QBE10 [2001309853]
7.4e-01
9.6e-01
—
1.0e+50
—
2.4e+00
1.2e+00
cases:0.96%
controls:0.46%
cases:0.30%
controls:0.12%
—
—
cases:0.78%
controls:0.00%
—
—
cases:0.97%
controls:0.09%
cases:1.46%
controls:0.44%
16
76
1649
16440
5
19
1660
16497
—
13
0
1652
16516
—
16
14
1628
16209
22
65
1487
14665
Supraglottic ventilation device
WX702 [2001310818]
WX702 [2001310818]
6.5e-01
8.1e-01
—
1.0e+50
—
2.4e+00
1.2e+00
cases:0.96%
controls:0.50%
cases:0.30%
controls:0.13%
—
—
cases:0.54%
controls:0.00%
—
—
cases:0.91%
controls:0.09%
cases:1.92%
controls:0.57%
16
83
1649
16433
5
22
1660
16494
—
9
0
1656
16516
—
15
14
1629
16209
29
84
1480
14646
Rheumatology
66 [38004491]
66 [38004491]
7.3e-01
8.4e-01
1.0e+00
—
9.0e-01
1.0e+00
9.8e-01
cases:5.41%
controls:2.68%
cases:3.84%
controls:1.70%
cases:0.84%
controls:0.31%
—
—
cases:0.90%
controls:0.37%
cases:4.44%
controls:1.61%
cases:7.69%
controls:3.03%
90
442
1575
16074
64
281
1601
16235
14
51
1651
16465
—
15
61
1650
16434
73
262
1571
15961
116
446
1393
14284
Essential (primary) hypertension
I10 [45591453]
I10 [45591453]
5.7e-02
1.4e-01
8.8e-01
2.7e+00
1.7e-01
7.6e-02
1.7e-01
cases:11.53%
controls:10.96%
cases:6.25%
controls:5.49%
cases:1.74%
controls:0.73%
cases:0.78%
controls:0.05%
cases:1.08%
controls:0.92%
cases:6.51%
controls:6.06%
cases:19.02%
controls:16.50%
192
1810
1473
14706
104
907
1561
15609
29
121
1636
16395
13
9
1652
16507
18
151
1647
16344
107
983
1537
15240
287
2431
1222
12299
Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
D17.1 [45566667]
D17.1 [45566667]
1.1e+00
2.0e+00
—
—
—
—
1.5e+00
cases:0.42%
controls:0.15%
cases:0.42%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.86%
controls:0.20%
7
24
1658
16492
7
9
1658
16507
—
—
—
—
13
29
1496
14701
Estimation of glomerular filtration rate
791801000000102 [44806420]
791801000000102 [44806420]
7.3e-01
1.4e+00
—
—
—
1.9e+00
1.6e+00
cases:0.60%
controls:0.29%
cases:0.42%
controls:0.10%
—
—
—
—
—
—
cases:0.43%
controls:0.06%
cases:0.86%
controls:0.18%
10
48
1655
16468
7
17
1658
16499
—
—
—
7
10
1637
16213
13
26
1496
14704
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
2.1e-01
4.2e-01
2.8e-01
1.7e+00
4.4e-01
4.7e-01
2.3e-01
cases:89.85%
controls:87.73%
cases:83.96%
controls:77.48%
cases:45.29%
controls:38.38%
cases:9.61%
controls:1.94%
cases:49.61%
controls:38.70%
cases:85.58%
controls:78.76%
cases:93.51%
controls:91.93%
1496
14490
169
2026
1398
12797
267
3719
754
6339
911
10177
160
320
1505
16196
826
6383
839
10112
1407
12777
237
3446
1411
13541
98
1189
Microorganisms panel - Urine sediment
58435-9 [40761536]
58435-9 [40761536]
3.3e-01
1.1e+00
—
—
—
1.1e+00
1.1e+00
cases:1.62%
controls:1.17%
cases:1.38%
controls:0.48%
—
—
—
—
—
—
cases:1.46%
controls:0.51%
cases:3.78%
controls:1.24%
27
193
1638
16323
23
79
1642
16437
—
—
—
24
82
1620
16141
57
182
1452
14548
oxycodone and naloxone; oral
N02AA55 [21604265]
N02AA55 [21604265]
6.3e-01
1.0e+00
—
—
1.3e+00
8.9e-01
7.3e-01
cases:2.16%
controls:1.17%
cases:1.20%
controls:0.44%
—
—
—
—
cases:0.30%
controls:0.08%
cases:1.22%
controls:0.51%
cases:4.37%
controls:2.17%
36
193
1629
16323
20
72
1645
16444
—
—
5
14
1660
16481
20
82
1624
16141
66
319
1443
14411
Noninvasive ventilation
WX725 [2001310828]
WX725 [2001310828]
7.6e-01
1.6e+00
—
—
—
1.8e+00
1.5e+00
cases:0.72%
controls:0.34%
cases:0.42%
controls:0.08%
—
—
—
—
—
—
cases:0.55%
controls:0.09%
cases:1.79%
controls:0.42%
12
56
1653
16460
7
14
1658
16502
—
—
—
9
15
1635
16208
27
62
1482
14668
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
4.5e-02
1.6e-01
4.9e-01
2.2e+00
3.7e-01
1.9e-01
8.6e-02
cases:30.81%
controls:29.87%
cases:31.41%
controls:28.14%
cases:12.73%
controls:8.20%
cases:3.96%
controls:0.47%
cases:11.53%
controls:8.23%
cases:34.00%
controls:29.86%
cases:48.31%
controls:46.16%
513
4933
1152
11583
523
4648
1142
11868
212
1354
1453
15162
66
77
1599
16439
192
1357
1473
15138
559
4844
1085
11379
729
6799
780
7931
Neurosurgery
14 [38004459]
14 [38004459]
5.6e-01
8.1e-01
5.7e-01
—
—
9.1e-01
9.3e-01
cases:3.48%
controls:2.02%
cases:1.80%
controls:0.81%
cases:0.30%
controls:0.17%
—
—
—
—
cases:1.82%
controls:0.75%
cases:5.04%
controls:2.05%
58
334
1607
16182
30
134
1635
16382
5
28
1660
16488
—
—
30
121
1614
16102
76
302
1433
14428
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
207NI0002X [38003841]
3.7e-01
6.1e-01
3.9e-01
—
1.1e+00
5.4e-01
5.7e-01
cases:8.29%
controls:5.87%
cases:4.56%
controls:2.54%
cases:0.60%
controls:0.41%
—
—
cases:1.14%
controls:0.39%
cases:4.20%
controls:2.48%
cases:10.54%
controls:6.27%
138
970
1527
15546
76
420
1589
16096
10
67
1655
16449
—
19
65
1646
16430
69
403
1575
15820
159
923
1350
13807
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-1.3e+00
-1.0e+00
-8.7e-01
-1.0e+50
1.1e+00
2.6e+00
2.8e+00
cases:9.37%
controls:26.78%
cases:3.18%
controls:8.44%
cases:0.36%
controls:0.86%
cases:0.00%
controls:0.04%
cases:0.30%
controls:0.10%
cases:4.74%
controls:0.37%
cases:12.86%
controls:0.86%
156
4423
1509
12093
53
1394
1612
15122
6
142
1659
16374
0
7
1665
16509
5
16
1660
16479
78
60
1566
16163
194
127
1315
14603
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
3.2e-01
4.3e-01
9.0e-01
—
1.6e+00
8.6e-01
3.5e-01
cases:9.37%
controls:6.95%
cases:3.42%
controls:2.26%
cases:0.84%
controls:0.35%
—
—
cases:1.56%
controls:0.33%
cases:4.68%
controls:2.03%
cases:9.01%
controls:6.55%
156
1148
1509
15368
57
373
1608
16143
14
57
1651
16459
—
26
54
1639
16441
77
330
1567
15893
136
965
1373
13765
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
60026-2 [40763086]
3.5e-01
5.4e-01
1.0e+00
—
2.9e-01
5.9e-01
4.5e-01
cases:7.51%
controls:5.39%
cases:4.50%
controls:2.67%
cases:0.84%
controls:0.30%
—
—
cases:0.42%
controls:0.32%
cases:4.99%
controls:2.83%
cases:13.65%
controls:9.12%
125
891
1540
15625
75
441
1590
16075
14
49
1651
16467
—
7
52
1658
16443
82
459
1562
15764
206
1344
1303
13386
methotrexate; oral, parenteral
L04AX03 [21603929]
L04AX03 [21603929]
6.4e-01
7.3e-01
6.3e-01
—
6.6e-01
7.3e-01
8.7e-01
cases:2.94%
controls:1.57%
cases:2.76%
controls:1.35%
cases:0.84%
controls:0.45%
—
—
cases:0.96%
controls:0.50%
cases:2.86%
controls:1.40%
cases:4.37%
controls:1.87%
49
259
1616
16257
46
223
1619
16293
14
74
1651
16442
—
16
82
1649
16413
47
227
1597
15996
66
276
1443
14454
methotrexate
L01BA01 [21601423]
L01BA01 [21601423]
6.4e-01
7.3e-01
6.3e-01
—
6.6e-01
7.3e-01
8.7e-01
cases:2.94%
controls:1.57%
cases:2.76%
controls:1.35%
cases:0.84%
controls:0.45%
—
—
cases:0.96%
controls:0.50%
cases:2.86%
controls:1.40%
cases:4.37%
controls:1.87%
49
259
1616
16257
46
223
1619
16293
14
74
1651
16442
—
16
82
1649
16413
47
227
1597
15996
66
276
1443
14454
Trichilemmal cyst
L72.1 [45596386]
L72.1 [45596386]
5.0e-01
1.3e+00
—
—
—
1.6e+00
3.9e-01
cases:0.90%
controls:0.55%
cases:0.66%
controls:0.18%
—
—
—
—
—
—
cases:0.73%
controls:0.14%
cases:0.99%
controls:0.67%
15
91
1650
16425
11
29
1654
16487
—
—
—
12
23
1632
16200
15
99
1494
14631
Lump/swelling localized
S04 [2002000969]
S04 [2002000969]
8.6e-01
2.1e+00
—
—
—
1.0e+00
6.6e-01
cases:1.68%
controls:0.72%
cases:1.68%
controls:0.22%
—
—
—
—
—
—
cases:0.73%
controls:0.27%
cases:2.05%
controls:1.07%
28
119
1637
16397
28
36
1637
16480
—
—
—
12
43
1632
16180
31
158
1478
14572
Treatment of reopened or infected surgical wound
SPAT1144 [2001700245]
SPAT1144 [2001700245]
6.6e-01
—
—
—
—
1.8e+00
1.1e+00
cases:0.90%
controls:0.47%
—
—
—
—
—
—
—
—
cases:0.85%
controls:0.14%
cases:1.26%
controls:0.42%
15
77
1650
16439
—
—
—
—
14
23
1630
16200
19
62
1490
14668
Erythrocyte [DistWidth] in Red Blood Cells by Automated count
788-0 [3019897]
788-0 [3019897]
1.3e+00
1.6e+00
—
—
—
—
3.1e-01
cases:0.90%
controls:0.24%
cases:0.60%
controls:0.13%
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.34%
15
39
1650
16477
10
21
1655
16495
—
—
—
—
7
50
1502
14680
Outpatient Hospital
22 [8756]
22 [8756]
3.3e-01
2.2e-01
6.0e-01
—
1.3e+00
7.7e-01
5.0e-01
cases:27.51%
controls:21.45%
cases:7.51%
controls:6.09%
cases:1.44%
controls:0.79%
—
—
cases:2.34%
controls:0.65%
cases:11.56%
controls:5.73%
cases:24.45%
controls:16.46%
458
3543
1207
12973
125
1006
1540
15510
24
131
1641
16385
—
39
107
1626
16388
190
929
1454
15294
369
2425
1140
12305
Mechanical complication of internal joint prosthesis
T84.0 [45570736]
T84.0 [45570736]
1.4e+00
1.6e+00
—
—
—
—
1.5e+00
cases:0.84%
controls:0.21%
cases:0.36%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.66%
controls:0.16%
14
34
1651
16482
6
12
1659
16504
—
—
—
—
10
23
1499
14707
hydroxychloroquine; oral
P01BA02 [21604889]
P01BA02 [21604889]
7.6e-01
5.3e-01
—
—
3.8e-01
9.3e-01
1.0e+00
cases:2.52%
controls:1.19%
cases:1.56%
controls:0.93%
—
—
—
—
cases:0.30%
controls:0.21%
cases:2.19%
controls:0.88%
cases:3.45%
controls:1.25%
42
197
1623
16319
26
153
1639
16363
—
—
5
34
1660
16461
36
142
1608
16081
52
184
1457
14546
Pain in joint
M25.5 [45586941]
M25.5 [45586941]
3.6e-01
6.4e-01
1.7e+00
—
—
4.1e-01
3.7e-01
cases:4.56%
controls:3.23%
cases:2.52%
controls:1.34%
cases:0.78%
controls:0.15%
—
—
—
—
cases:1.89%
controls:1.26%
cases:7.09%
controls:4.99%
76
533
1589
15983
42
222
1623
16294
13
24
1652
16492
—
—
31
204
1613
16019
107
735
1402
13995
Brachial plexus disorders
G54.0 [45586302]
G54.0 [45586302]
1.3e+00
—
—
—
—
—
1.4e+00
cases:0.66%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
cases:0.80%
controls:0.20%
11
30
1654
16486
—
—
—
—
—
12
30
1497
14700
beclometasone; nasal
R01AD01 [21605043]
R01AD01 [21605043]
5.6e-01
9.9e-01
—
—
1.7e+00
1.0e+00
6.6e-01
cases:2.40%
controls:1.38%
cases:1.32%
controls:0.50%
—
—
—
—
cases:0.42%
controls:0.08%
cases:1.16%
controls:0.43%
cases:2.19%
controls:1.14%
40
228
1625
16288
22
82
1643
16434
—
—
7
13
1658
16482
19
69
1625
16154
33
168
1476
14562
Ophthalmology
18 [38004463]
18 [38004463]
2.0e-01
2.6e-01
-1.7e-01
2.6e+00
2.5e-01
7.5e-02
2.0e-01
cases:13.03%
controls:10.97%
cases:6.49%
controls:5.06%
cases:0.78%
controls:0.92%
cases:0.48%
controls:0.04%
cases:1.14%
controls:0.89%
cases:5.84%
controls:5.44%
cases:16.90%
controls:14.24%
217
1811
1448
14705
108
835
1557
15681
13
152
1652
16364
8
6
1657
16510
19
147
1646
16348
96
883
1548
15340
255
2097
1254
12633
Lumbar and other intervertebral disc disorders with radiculopathy
M51.1 [45562747]
M51.1 [45562747]
6.8e-01
7.7e-01
—
—
-1.0e+50
9.5e-01
9.5e-01
cases:3.00%
controls:1.54%
cases:1.20%
controls:0.56%
—
—
—
—
cases:0.00%
controls:0.07%
cases:1.22%
controls:0.47%
cases:4.17%
controls:1.66%
50
255
1615
16261
20
92
1645
16424
—
—
0
12
1665
16483
20
77
1624
16146
63
245
1446
14485
Wrist and hand extensive MRI examination with high intensity magnet
ND1CG [2001307593]
ND1CG [2001307593]
-1.0e+50
2.3e+00
—
1.0e+50
—
—
2.6e+00
cases:0.00%
controls:0.04%
cases:0.30%
controls:0.03%
—
—
cases:0.60%
controls:0.00%
—
—
—
—
cases:0.53%
controls:0.04%
0
7
1665
16509
5
5
1660
16511
—
10
0
1655
16516
—
—
8
6
1501
14724
Decompression of lumbar nerve roots
ABC36 [2001300475]
ABC36 [2001300475]
1.4e+00
1.4e+00
—
—
—
—
1.2e+00
cases:0.84%
controls:0.22%
cases:0.30%
controls:0.07%
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.32%
14
36
1651
16480
5
12
1660
16504
—
—
—
—
16
47
1493
14683
azithromycin; oral, parenteral
J01FA10 [21602978]
J01FA10 [21602978]
3.6e-01
5.1e-01
1.3e+00
—
5.6e-01
3.8e-01
3.7e-01
cases:13.33%
controls:9.69%
cases:4.50%
controls:2.74%
cases:0.66%
controls:0.18%
—
—
cases:0.60%
controls:0.35%
cases:3.53%
controls:2.43%
cases:10.27%
controls:7.34%
222
1600
1443
14916
75
453
1590
16063
11
30
1654
16486
—
10
57
1655
16438
58
395
1586
15828
155
1081
1354
13649
Excision of other lesion extending through all layers of skin in head or neck
QAE10 [2001309784]
QAE10 [2001309784]
1.6e-01
9.5e-01
—
—
—
1.6e+00
9.5e-01
cases:0.48%
controls:0.41%
cases:0.42%
controls:0.16%
—
—
—
—
—
—
cases:0.67%
controls:0.14%
cases:1.52%
controls:0.60%
8
68
1657
16448
7
27
1658
16489
—
—
—
11
23
1633
16200
23
88
1486
14642
Connective tissue diseases, rheumatoid arthritis and comparable disease
202 [2001600200]
202 [2001600200]
3.8e-01
6.2e-01
—
—
—
1.6e+00
9.0e-01
cases:0.96%
controls:0.66%
cases:0.36%
controls:0.19%
—
—
—
—
—
—
cases:0.61%
controls:0.12%
cases:1.52%
controls:0.62%
16
109
1649
16407
6
32
1659
16484
—
—
—
10
20
1634
16203
23
92
1486
14638
Otolaryngology
4 [38004449]
4 [38004449]
5.9e-01
4.5e-01
8.0e-01
1.0e+50
9.3e-01
1.9e-01
5.3e-01
cases:15.74%
controls:9.36%
cases:5.23%
controls:3.40%
cases:0.96%
controls:0.44%
cases:0.30%
controls:0.00%
cases:1.08%
controls:0.43%
cases:3.95%
controls:3.29%
cases:15.51%
controls:9.75%
262
1546
1403
14970
87
562
1578
15954
16
72
1649
16444
5
0
1660
16516
18
71
1647
16424
65
534
1579
15689
234
1436
1275
13294
Head and body CT examination for trauma
JN5BD [2001310923]
JN5BD [2001310923]
2.5e+00
—
—
—
—
—
—
cases:0.36%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
—
—
6
5
1659
16511
—
—
—
—
—
—
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
Z50.8 [45556842]
8.9e-02
7.7e-01
2.5e+00
—
—
8.8e-01
6.3e-01
cases:0.72%
controls:0.66%
cases:0.48%
controls:0.22%
cases:0.36%
controls:0.03%
—
—
—
—
cases:0.55%
controls:0.23%
cases:1.19%
controls:0.64%
12
109
1653
16407
8
37
1657
16479
6
5
1659
16511
—
—
9
37
1635
16186
18
94
1491
14636
Benign neoplasm: Connective and other soft tissue of head, face and neck
D21.0 [45561902]
D21.0 [45561902]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.03%
—
—
—
—
—
—
6
5
1503
14725
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
2514-8 [3035350]
3.0e-01
5.0e-01
1.1e+00
—
3.8e-01
5.6e-01
3.1e-01
cases:8.23%
controls:6.22%
cases:5.41%
controls:3.34%
cases:1.08%
controls:0.38%
—
—
cases:0.60%
controls:0.41%
cases:6.39%
controls:3.75%
cases:15.64%
controls:12.01%
137
1028
1528
15488
90
552
1575
15964
18
62
1647
16454
—
10
68
1655
16427
105
608
1539
15615
236
1769
1273
12961
Uvulopalatopharyngoplasty
ENC40 [2001302321]
ENC40 [2001302321]
2.4e+00
—
—
—
—
—
—
cases:0.48%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
—
—
8
7
1657
16509
—
—
—
—
—
—
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
25428-4 [3009261]
2.9e-01
5.0e-01
1.0e+00
—
2.7e-01
5.4e-01
3.1e-01
cases:8.23%
controls:6.32%
cases:5.41%
controls:3.36%
cases:1.08%
controls:0.38%
—
—
cases:0.54%
controls:0.41%
cases:6.33%
controls:3.79%
cases:15.77%
controls:12.11%
137
1043
1528
15473
90
555
1575
15961
18
63
1647
16453
—
9
68
1656
16427
104
615
1540
15608
238
1784
1271
12946
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
5802-4 [3021601]
3.1e-01
4.9e-01
1.0e+00
—
3.0e-01
5.5e-01
3.0e-01
cases:8.17%
controls:6.13%
cases:5.23%
controls:3.26%
cases:1.02%
controls:0.37%
—
—
cases:0.54%
controls:0.40%
cases:6.14%
controls:3.64%
cases:15.24%
controls:11.77%
136
1012
1529
15504
87
538
1578
15978
17
61
1648
16455
—
9
66
1656
16429
101
590
1543
15633
230
1734
1279
12996
Hyperplasia of prostate
N40 [45563015]
N40 [45563015]
2.4e-01
3.0e-01
1.2e+00
—
1.8e+00
6.7e-01
5.6e-01
cases:2.28%
controls:1.80%
cases:1.08%
controls:0.81%
cases:0.48%
controls:0.15%
—
—
cases:0.66%
controls:0.11%
cases:1.64%
controls:0.85%
cases:4.11%
controls:2.40%
38
297
1627
16219
18
133
1647
16383
8
25
1657
16491
—
11
18
1654
16477
27
138
1617
16085
62
353
1447
14377
Total synovectomy of knee, arthroscopic
NGF15 [2001308131]
NGF15 [2001308131]
2.3e+00
—
—
—
—
—
—
cases:0.42%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
—
—
7
7
1658
16509
—
—
—
—
—
—
Transanal ultrasonography
XJH00 [2001305132]
XJH00 [2001305132]
4.5e-01
—
—
—
—
2.3e+00
8.2e-01
cases:0.36%
controls:0.23%
—
—
—
—
—
—
—
—
cases:0.55%
controls:0.06%
cases:0.60%
controls:0.26%
6
38
1659
16478
—
—
—
—
9
9
1635
16214
9
39
1500
14691
Bone marrow biopsy
XW000 [2001310618]
XW000 [2001310618]
—
—
—
—
—
2.3e+00
9.5e-01
—
—
—
—
—
—
—
—
—
—
cases:0.36%
controls:0.04%
cases:0.60%
controls:0.23%
—
—
—
—
—
6
6
1638
16217
9
34
1500
14696
Other primary arthrosis of first carpometacarpal joint
M18.1 [45538684]
M18.1 [45538684]
1.4e+00
—
—
—
—
2.3e+00
1.2e+00
cases:0.42%
controls:0.10%
—
—
—
—
—
—
—
—
cases:0.36%
controls:0.04%
cases:0.40%
controls:0.12%
7
17
1658
16499
—
—
—
—
6
6
1638
16217
6
18
1503
14712
Other specified special examinations
Z01.8 [45581003]
Z01.8 [45581003]
5.5e-01
7.5e-01
1.4e+00
—
—
9.9e-01
7.5e-01
cases:3.72%
controls:2.18%
cases:1.32%
controls:0.63%
cases:0.42%
controls:0.11%
—
—
—
—
cases:1.64%
controls:0.62%
cases:5.24%
controls:2.55%
62
360
1603
16156
22
104
1643
16412
7
18
1658
16498
—
—
27
100
1617
16123
79
375
1430
14355
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
N02AX02 [21604298]
4.9e-01
5.2e-01
4.0e-01
—
2.3e-01
5.3e-01
6.7e-01
cases:9.79%
controls:6.26%
cases:3.78%
controls:2.28%
cases:0.54%
controls:0.36%
—
—
cases:0.66%
controls:0.53%
cases:3.65%
controls:2.19%
cases:11.40%
controls:6.15%
163
1034
1502
15482
63
376
1602
16140
9
60
1656
16456
—
11
87
1654
16408
60
355
1584
15868
172
906
1337
13824
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
D48.0 [45586112]
D48.0 [45586112]
2.2e+00
—
1.0e+50
—
1.0e+50
—
1.6e+00
cases:0.48%
controls:0.05%
—
—
cases:0.48%
controls:0.00%
—
—
cases:0.30%
controls:0.00%
—
—
cases:0.33%
controls:0.07%
8
9
1657
16507
—
8
0
1657
16516
—
5
0
1660
16495
—
5
10
1504
14720
Arthrocentesis, unspecified region, unspecified region
TNX10 [2001308560]
TNX10 [2001308560]
6.5e-01
7.8e-01
—
—
—
1.3e+00
8.8e-01
cases:1.14%
controls:0.60%
cases:0.42%
controls:0.19%
—
—
—
—
—
—
cases:0.85%
controls:0.23%
cases:1.33%
controls:0.56%
19
99
1646
16417
7
32
1658
16484
—
—
—
14
38
1630
16185
20
82
1489
14648
triptorelin; parenteral
L02AE04 [21603827]
L02AE04 [21603827]
2.2e+00
—
—
—
—
—
—
cases:0.42%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
—
—
7
8
1658
16508
—
—
—
—
—
—
Rotator cuff syndrome
M75.1 [45596678]
M75.1 [45596678]
6.2e-01
8.3e-01
1.1e+00
—
—
5.5e-01
6.9e-01
cases:4.92%
controls:2.70%
cases:2.16%
controls:0.95%
cases:0.54%
controls:0.18%
—
—
—
—
cases:1.82%
controls:1.06%
cases:7.22%
controls:3.77%
82
446
1583
16070
36
157
1629
16359
9
29
1656
16487
—
—
30
172
1614
16051
109
555
1400
14175
Laparoscopic cholangiography
TJK01 [2001305287]
TJK01 [2001305287]
2.1e+00
—
—
—
—
—
—
cases:0.36%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
—
—
6
7
1659
16509
—
—
—
—
—
—
Localized swelling, mass and lump of skin and subcutaneous tissue
R22 [45573018]
R22 [45573018]
—
2.1e+00
—
—
—
-1.0e+50
—
—
—
cases:0.36%
controls:0.04%
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
—
6
7
1659
16509
—
—
—
0
9
1644
16214
—
Infiltration anesthesia
WX110 [2001310767]
WX110 [2001310767]
9.7e-02
2.1e-01
5.3e-01
—
1.3e+00
5.8e-01
2.6e-01
cases:16.34%
controls:15.05%
cases:7.27%
controls:5.96%
cases:1.32%
controls:0.78%
—
—
cases:2.70%
controls:0.75%
cases:10.16%
controls:5.95%
cases:22.86%
controls:18.59%
272
2486
1393
14030
121
985
1544
15531
22
129
1643
16387
—
45
124
1620
16371
167
965
1477
15258
345
2738
1164
11992
Pediatric Surgery
OMOP4822020 [45756819]
OMOP4822020 [45756819]
—
-1.0e+50
—
1.0e+50
—
2.1e+00
1.0e+00
—
—
cases:0.00%
controls:0.04%
—
—
cases:0.30%
controls:0.00%
—
—
cases:0.36%
controls:0.04%
cases:0.40%
controls:0.14%
—
0
7
1665
16509
—
5
0
1660
16516
—
6
7
1638
16216
6
21
1503
14709
Hand and fingers extensive X-ray examination
ND2BA [2001307610]
ND2BA [2001307610]
—
2.0e+00
—
—
—
—
2.1e+00
—
—
cases:0.30%
controls:0.04%
—
—
—
—
—
—
—
—
cases:1.26%
controls:0.16%
—
5
7
1660
16509
—
—
—
—
19
23
1490
14707
Intubation
WX704 [2001310820]
WX704 [2001310820]
3.6e-01
9.1e-01
—
—
—
1.3e+00
7.6e-01
cases:1.08%
controls:0.76%
cases:0.54%
controls:0.22%
—
—
—
—
—
—
cases:0.67%
controls:0.18%
cases:2.05%
controls:0.97%
18
125
1647
16391
9
36
1656
16480
—
—
—
11
29
1633
16194
31
143
1478
14587
tizanidine; oral
M03BX02 [21604116]
M03BX02 [21604116]
4.8e-01
6.2e-01
3.9e-01
—
4.7e-01
4.5e-01
5.2e-01
cases:19.70%
controls:13.19%
cases:7.39%
controls:4.11%
cases:0.72%
controls:0.49%
—
—
cases:0.90%
controls:0.56%
cases:6.63%
controls:4.31%
cases:19.48%
controls:12.59%
328
2179
1337
14337
123
679
1542
15837
12
81
1653
16435
—
15
93
1650
16402
109
700
1535
15523
294
1854
1215
12876
Shoulder and humerus very extensive MRI examination with high intensity magnet
NB1DG [2001307242]
NB1DG [2001307242]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.07%
—
—
—
—
—
—
8
10
1501
14720
12 lead EKG panel
34534-8 [3044889]
34534-8 [3044889]
2.1e-01
3.9e-01
8.0e-01
—
7.9e-01
5.0e-01
3.6e-01
cases:13.15%
controls:10.93%
cases:8.35%
controls:5.81%
cases:1.56%
controls:0.71%
—
—
cases:1.26%
controls:0.58%
cases:9.49%
controls:5.98%
cases:23.06%
controls:17.24%
219
1805
1446
14711
139
959
1526
15557
26
117
1639
16399
—
21
95
1644
16400
156
970
1488
15253
348
2540
1161
12190
Cough
R05 [2002000886]
R05 [2002000886]
2.3e-01
3.6e-02
—
—
2.0e+00
5.8e-01
2.4e-01
cases:3.06%
controls:2.44%
cases:0.84%
controls:0.81%
—
—
—
—
cases:0.42%
controls:0.05%
cases:1.46%
controls:0.83%
cases:4.37%
controls:3.49%
51
403
1614
16113
14
134
1651
16382
—
—
7
9
1658
16486
24
134
1620
16089
66
514
1443
14216
Other primary gonarthrosis
M17.1 [45596493]
M17.1 [45596493]
6.9e-01
8.7e-01
—
—
—
6.7e-01
4.5e-01
cases:4.26%
controls:2.18%
cases:1.86%
controls:0.79%
—
—
—
—
—
—
cases:1.70%
controls:0.88%
cases:4.77%
controls:3.10%
71
360
1594
16156
31
130
1634
16386
—
—
—
28
142
1616
16081
72
456
1437
14274
Ultrsound examination of soft tissue not elsewhere classified
QX2XE [2001310033]
QX2XE [2001310033]
1.2e+00
2.0e+00
—
—
—
2.3e+00
5.6e-01
cases:0.48%
controls:0.14%
cases:0.54%
controls:0.07%
—
—
—
—
—
—
cases:0.30%
controls:0.03%
cases:0.33%
controls:0.19%
8
23
1657
16493
9
12
1656
16504
—
—
—
5
5
1639
16218
5
28
1504
14702
Transduodenal endoscopic incision of common bile duct orifice
JKE02 [2001305327]
JKE02 [2001305327]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.05%
—
—
—
—
—
—
6
8
1503
14722
Fracture of other and unspecified parts of lumbar spine and pelvis
S32.8 [45573423]
S32.8 [45573423]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.05%
—
—
—
—
—
—
6
8
1503
14722
Other blockage of nerve
WX290 [2001310792]
WX290 [2001310792]
9.9e-02
2.1e-01
3.7e-01
—
1.4e+00
5.9e-01
2.1e-01
cases:8.71%
controls:7.95%
cases:3.42%
controls:2.79%
cases:0.48%
controls:0.33%
—
—
cases:1.26%
controls:0.32%
cases:5.17%
controls:2.93%
cases:11.86%
controls:9.82%
145
1313
1520
15203
57
461
1608
16055
8
55
1657
16461
—
21
52
1644
16443
85
476
1559
15747
179
1447
1330
13283
Shoulder and humerus extensive MRI examination with high intensity magnet
NB1CG [2001307237]
NB1CG [2001307237]
7.2e-01
—
—
—
—
—
2.0e+00
cases:0.36%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
cases:0.73%
controls:0.10%
6
29
1659
16487
—
—
—
—
—
11
15
1498
14715
Other specified disorders of synovium and tendon
M67.8 [45562807]
M67.8 [45562807]
1.9e+00
—
—
—
—
—
—
cases:0.42%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
—
7
10
1658
16506
—
—
—
—
—
—
Cryotherapy
ZXC50 [2001311370]
ZXC50 [2001311370]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.80%
controls:0.12%
—
—
—
—
—
—
12
17
1497
14713
golimumab; parenteral
L04AB06 [21603913]
L04AB06 [21603913]
1.3e+00
—
—
—
—
—
1.9e+00
cases:0.30%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.07%
5
13
1660
16503
—
—
—
—
—
7
10
1502
14720
Cyclic citrullinated peptide Ab [Units/volume] in Serum
53027-9 [3041942]
53027-9 [3041942]
5.1e-01
5.7e-01
1.2e+00
—
—
8.7e-01
5.3e-01
cases:3.36%
controls:2.05%
cases:1.26%
controls:0.72%
cases:0.30%
controls:0.09%
—
—
—
—
cases:1.64%
controls:0.70%
cases:5.04%
controls:3.02%
56
338
1609
16178
21
119
1644
16397
5
15
1660
16501
—
—
27
113
1617
16110
76
445
1433
14285
Lesion of ulnar nerve
G56.2 [45595951]
G56.2 [45595951]
6.9e-01
1.9e+00
—
—
—
—
9.5e-01
cases:0.48%
controls:0.24%
cases:0.60%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.66%
controls:0.26%
8
40
1657
16476
10
15
1655
16501
—
—
—
—
10
38
1499
14692
Unilateral lobectomy of thyroid gland
BAA40 [2001300751]
BAA40 [2001300751]
1.9e+00
—
—
—
—
—
1.0e+00
cases:0.60%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:0.33%
controls:0.12%
10
15
1655
16501
—
—
—
—
—
5
18
1504
14712
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
53292-9 [3041096]
4.0e-01
5.7e-01
9.5e-01
—
—
5.3e-01
3.8e-01
cases:5.29%
controls:3.61%
cases:3.18%
controls:1.83%
cases:0.42%
controls:0.16%
—
—
—
—
cases:3.10%
controls:1.85%
cases:8.42%
controls:5.89%
88
597
1577
15919
53
302
1612
16214
7
27
1658
16489
—
—
51
300
1593
15923
127
868
1382
13862
General anesthesia, balanced
WX408 [2001310808]
WX408 [2001310808]
2.5e-01
2.2e-01
—
—
—
1.3e+00
5.3e-01
cases:3.84%
controls:3.01%
cases:0.96%
controls:0.77%
—
—
—
—
—
—
cases:2.13%
controls:0.57%
cases:3.45%
controls:2.06%
64
497
1601
16019
16
127
1649
16389
—
—
—
35
92
1609
16131
52
304
1457
14426
Hemorrhoidectomy
JHB00 [2001305139]
JHB00 [2001305139]
—
—
—
—
—
-1.0e+50
1.8e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.03%
cases:0.60%
controls:0.10%
—
—
—
—
—
0
5
1644
16218
9
14
1500
14716
Remowal of suture of skin
TQW40 [2001310146]
TQW40 [2001310146]
3.7e-01
—
—
—
—
1.8e+00
8.3e-01
cases:0.72%
controls:0.50%
—
—
—
—
—
—
—
—
cases:0.43%
controls:0.07%
cases:0.99%
controls:0.43%
12
82
1653
16434
—
—
—
—
7
11
1637
16212
15
64
1494
14666
esomeprazole; oral, parenteral
A02BC05 [21600100]
A02BC05 [21600100]
4.5e-01
3.8e-01
3.7e-01
—
1.7e-01
5.4e-01
4.6e-01
cases:10.69%
controls:7.08%
cases:5.65%
controls:3.94%
cases:1.26%
controls:0.88%
—
—
cases:0.90%
controls:0.76%
cases:6.02%
controls:3.61%
cases:11.60%
controls:7.66%
178
1170
1487
15346
94
650
1571
15866
21
145
1644
16371
—
15
126
1650
16369
99
586
1545
15637
175
1129
1334
13601
Granulocytes [#/volume] in Blood
30394-1 [3035715]
30394-1 [3035715]
9.8e-02
—
—
—
—
1.8e+00
1.8e+00
cases:0.30%
controls:0.27%
—
—
—
—
—
—
—
—
cases:0.30%
controls:0.05%
cases:0.99%
controls:0.16%
5
45
1660
16471
—
—
—
—
5
8
1639
16215
15
24
1494
14706
Wrist and hand MRI examination with high intensity magnet
ND1BG [2001307586]
ND1BG [2001307586]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.66%
controls:0.11%
—
—
—
—
—
—
10
16
1499
14714
amitriptyline; oral, parenteral
N06AA09 [21604696]
N06AA09 [21604696]
3.9e-01
5.3e-01
3.2e-01
-1.0e+50
6.7e-01
6.9e-01
5.8e-01
cases:5.11%
controls:3.50%
cases:3.18%
controls:1.90%
cases:0.54%
controls:0.39%
cases:0.00%
controls:0.03%
cases:0.72%
controls:0.37%
cases:3.47%
controls:1.77%
cases:6.63%
controls:3.82%
85
578
1580
15938
53
314
1612
16202
9
65
1656
16451
0
5
1665
16511
12
61
1653
16434
57
287
1587
15936
100
562
1409
14168
gabapentin; oral
N02BF01 [955005]
N02BF01 [955005]
6.3e-01
6.9e-01
5.9e-01
—
4.5e-01
5.1e-01
4.7e-01
cases:3.48%
controls:1.90%
cases:2.22%
controls:1.13%
cases:0.72%
controls:0.40%
—
—
cases:0.60%
controls:0.38%
cases:2.01%
controls:1.22%
cases:4.90%
controls:3.13%
58
313
1607
16203
37
186
1628
16330
12
66
1653
16450
—
10
63
1655
16432
33
198
1611
16025
74
461
1435
14269
Flail joint
M25.2 [45567527]
M25.2 [45567527]
1.8e+00
—
—
—
—
—
—
cases:0.42%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
—
—
7
12
1658
16504
—
—
—
—
—
—
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
57782-5 [40760892]
4.6e-01
3.2e-01
9.6e-01
—
8.6e-01
6.6e-01
6.2e-01
cases:4.32%
controls:2.77%
cases:2.34%
controls:1.71%
cases:0.66%
controls:0.25%
—
—
cases:0.54%
controls:0.23%
cases:3.04%
controls:1.60%
cases:8.28%
controls:4.62%
72
458
1593
16058
39
283
1626
16233
11
42
1654
16474
—
9
38
1656
16457
50
260
1594
15963
125
680
1384
14050
miconazole
S02AA13 [21605159]
S02AA13 [21605159]
1.2e-01
1.7e+00
—
—
—
—
2.3e-01
cases:0.60%
controls:0.53%
cases:0.48%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.60%
controls:0.48%
10
88
1655
16428
8
14
1657
16502
—
—
—
—
9
70
1500
14660
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
D48.9 [45532986]
D48.9 [45532986]
1.6e+00
—
—
—
—
—
1.7e+00
cases:0.36%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.10%
6
12
1659
16504
—
—
—
—
—
8
14
1501
14716
Inflammatory spondylopathy, unspecified
M46.9 [45533846]
M46.9 [45533846]
1.0e+00
2.0e+00
—
—
—
—
1.7e+00
cases:0.30%
controls:0.11%
cases:0.30%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.10%
5
18
1660
16498
5
7
1660
16509
—
—
—
—
8
14
1501
14716
Benign neoplasm: Skin of other and unspecified parts of face
D23.3 [45595740]
D23.3 [45595740]
1.7e+00
—
—
—
—
—
5.2e-01
cases:0.66%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.24%
11
20
1654
16496
—
—
—
—
—
6
35
1503
14695
Seropositive rheumatoid arthritis
M05 [45606038]
M05 [45606038]
1.1e+00
—
—
—
—
—
1.7e+00
cases:0.60%
controls:0.21%
—
—
—
—
—
—
—
—
—
—
cases:0.66%
controls:0.12%
10
34
1655
16482
—
—
—
—
—
10
18
1499
14712
meloxicam; oral, parenteral, rectal
M01AC06 [21603965]
M01AC06 [21603965]
4.1e-01
6.4e-01
1.3e+00
—
—
4.6e-01
6.4e-01
cases:7.03%
controls:4.79%
cases:2.82%
controls:1.51%
cases:0.54%
controls:0.15%
—
—
—
—
cases:2.37%
controls:1.50%
cases:8.75%
controls:4.80%
117
791
1548
15725
47
249
1618
16267
9
25
1656
16491
—
—
39
244
1605
15979
132
707
1377
14023
Incision for biopsy of skin of head or neck
QAA05 [2001309761]
QAA05 [2001309761]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.73%
controls:0.14%
—
—
—
—
—
—
11
20
1498
14710
Fracture of other finger
S62.6 [45564362]
S62.6 [45564362]
2.9e-01
1.7e+00
—
—
—
—
8.5e-01
cases:0.42%
controls:0.31%
cases:0.48%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.99%
controls:0.43%
7
52
1658
16464
8
15
1657
16501
—
—
—
—
15
63
1494
14667
Spinal stenosis
M48.0 [45557888]
M48.0 [45557888]
8.0e-01
8.3e-01
1.2e+00
—
—
8.4e-01
8.4e-01
cases:2.10%
controls:0.96%
cases:1.08%
controls:0.47%
cases:0.36%
controls:0.11%
—
—
—
—
cases:1.09%
controls:0.47%
cases:3.11%
controls:1.36%
35
158
1630
16358
18
78
1647
16438
6
18
1659
16498
—
—
18
77
1626
16146
47
201
1462
14529
General anaesthesia
WX402 [2001310806]
WX402 [2001310806]
-8.2e-03
5.8e-01
—
—
1.5e+00
1.1e+00
5.1e-01
cases:1.38%
controls:1.39%
cases:1.14%
controls:0.64%
—
—
—
—
cases:0.42%
controls:0.09%
cases:1.64%
controls:0.54%
cases:4.24%
controls:2.59%
23
230
1642
16286
19
106
1646
16410
—
—
7
15
1658
16480
27
88
1617
16135
64
381
1445
14349
diclofenac; oral, parenteral, rectal
M01AB05 [21603945]
M01AB05 [21603945]
3.4e-01
4.9e-01
4.4e-01
—
2.4e-01
4.0e-01
4.0e-01
cases:20.00%
controls:15.12%
cases:7.15%
controls:4.51%
cases:0.96%
controls:0.62%
—
—
cases:0.90%
controls:0.71%
cases:7.12%
controls:4.90%
cases:19.22%
controls:13.75%
333
2498
1332
14018
119
745
1546
15771
16
103
1649
16413
—
15
117
1650
16378
117
795
1527
15428
290
2025
1219
12705
Gastro-oesophageal reflux disease with oesophagitis
K21.0 [45543296]
K21.0 [45543296]
8.4e-01
—
—
—
—
—
7.7e-01
cases:1.92%
controls:0.84%
—
—
—
—
—
—
—
—
—
—
cases:2.12%
controls:1.00%
32
138
1633
16378
—
—
—
—
—
32
147
1477
14583
Granulocytes/Leukocytes in Blood
30395-8 [3035933]
30395-8 [3035933]
-4.7e-02
—
—
—
—
1.5e+00
1.6e+00
cases:0.30%
controls:0.31%
—
—
—
—
—
—
—
—
cases:0.36%
controls:0.08%
cases:0.99%
controls:0.20%
5
52
1660
16464
—
—
—
—
6
13
1638
16210
15
30
1494
14700
Nonorganic sleep disorder, unspecified
F51.9 [45605503]
F51.9 [45605503]
-1.0e+50
—
—
—
—
—
1.6e+00
cases:0.00%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:0.60%
controls:0.12%
0
20
1665
16496
—
—
—
—
—
9
18
1500
14712
Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs
D17.2 [45561898]
D17.2 [45561898]
1.6e+00
—
—
—
—
—
8.0e-01
cases:0.66%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
cases:0.33%
controls:0.15%
11
23
1654
16493
—
—
—
—
—
5
22
1504
14708
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
1.7e-01
2.7e-01
5.9e-01
1.2e+00
4.3e-01
4.5e-01
2.3e-01
cases:24.68%
controls:21.68%
cases:18.62%
controls:14.88%
cases:4.62%
controls:2.62%
cases:0.54%
controls:0.16%
cases:3.72%
controls:2.44%
cases:21.59%
controls:14.96%
cases:38.30%
controls:33.08%
411
3581
1254
12935
310
2457
1355
14059
77
433
1588
16083
9
26
1656
16490
62
403
1603
16092
355
2427
1289
13796
578
4873
931
9857
Other spondylosis, multiple sites in spine
M47.80 [42617655]
M47.80 [42617655]
6.5e-01
—
—
—
—
—
1.5e+00
cases:0.36%
controls:0.19%
—
—
—
—
—
—
—
—
—
—
cases:0.99%
controls:0.22%
6
31
1659
16485
—
—
—
—
—
15
32
1494
14698
orphenadrine (chloride); oral, parenteral
N04AB02 [21604458]
N04AB02 [21604458]
2.4e-01
5.7e-01
4.0e-01
—
5.3e-01
5.9e-01
3.7e-01
cases:7.75%
controls:6.22%
cases:3.36%
controls:1.93%
cases:0.36%
controls:0.24%
—
—
cases:0.36%
controls:0.21%
cases:3.35%
controls:1.88%
cases:9.15%
controls:6.52%
129
1027
1536
15489
56
319
1609
16197
6
40
1659
16476
—
6
35
1659
16460
55
305
1589
15918
138
960
1371
13770
orphenadrine (citrate); oral, parenteral
M03BC01 [21604112]
M03BC01 [21604112]
2.4e-01
5.7e-01
4.0e-01
—
5.3e-01
5.9e-01
3.7e-01
cases:7.75%
controls:6.22%
cases:3.36%
controls:1.93%
cases:0.36%
controls:0.24%
—
—
cases:0.36%
controls:0.21%
cases:3.35%
controls:1.88%
cases:9.15%
controls:6.52%
129
1027
1536
15489
56
319
1609
16197
6
40
1659
16476
—
6
35
1659
16460
55
305
1589
15918
138
960
1371
13770
Other synovitis and tenosynovitis
M65.8 [45582208]
M65.8 [45582208]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.80%
controls:0.18%
—
—
—
—
—
—
12
26
1497
14704
Intravenous general anesthesia
WX404 [2001310807]
WX404 [2001310807]
-2.0e-01
-7.1e-01
—
1.0e+50
-1.0e+50
8.8e-01
6.2e-01
cases:1.68%
controls:2.05%
cases:0.36%
controls:0.73%
—
—
cases:0.48%
controls:0.00%
cases:0.00%
controls:0.07%
cases:1.16%
controls:0.48%
cases:2.58%
controls:1.41%
28
339
1637
16177
6
121
1659
16395
—
8
0
1657
16516
0
12
1665
16483
19
78
1625
16145
39
207
1470
14523
Blasts/Leukocytes in Blood
26446-5 [3025159]
26446-5 [3025159]
8.8e-01
5.3e-01
1.4e+00
—
1.3e+00
7.5e-01
6.1e-01
cases:1.32%
controls:0.55%
cases:0.84%
controls:0.50%
cases:0.42%
controls:0.10%
—
—
cases:0.30%
controls:0.08%
cases:1.22%
controls:0.58%
cases:2.78%
controls:1.53%
22
91
1643
16425
14
82
1651
16434
7
17
1658
16499
—
5
14
1660
16481
20
94
1624
16129
42
225
1467
14505
Palmar fasciotomy of hand
NDM10 [2001307724]
NDM10 [2001307724]
5.7e-01
—
—
1.0e+50
—
2.3e+00
1.5e+00
cases:0.30%
controls:0.17%
—
—
—
—
cases:0.36%
controls:0.00%
—
—
cases:0.30%
controls:0.03%
cases:0.60%
controls:0.14%
5
28
1660
16488
—
—
6
0
1659
16516
—
5
5
1639
16218
9
20
1500
14710
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
34548-8 [3045783]
1.5e-02
3.3e-01
1.2e+00
—
1.3e+00
7.7e-01
7.1e-01
cases:2.10%
controls:2.07%
cases:1.26%
controls:0.91%
cases:0.36%
controls:0.11%
—
—
cases:0.36%
controls:0.10%
cases:1.82%
controls:0.86%
cases:5.10%
controls:2.57%
35
342
1630
16174
21
150
1644
16366
6
18
1659
16498
—
6
17
1659
16478
30
139
1614
16084
77
378
1432
14352
Inhalation anesthesia
WX400 [2001310805]
WX400 [2001310805]
7.8e-01
—
—
—
—
—
1.5e+00
cases:0.84%
controls:0.39%
—
—
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.24%
14
64
1651
16452
—
—
—
—
—
16
36
1493
14694
Chloride [Moles/volume] in Blood
2069-3 [3018572]
2069-3 [3018572]
1.5e+00
—
—
—
—
1.3e+00
7.3e-01
cases:0.60%
controls:0.14%
—
—
—
—
—
—
—
—
cases:0.30%
controls:0.08%
cases:0.66%
controls:0.32%
10
23
1655
16493
—
—
—
—
5
13
1639
16210
10
47
1499
14683
Anion gap in Blood by calculation
41276-7 [3039000]
41276-7 [3039000]
1.5e+00
—
—
—
—
1.3e+00
7.3e-01
cases:0.60%
controls:0.14%
—
—
—
—
—
—
—
—
cases:0.30%
controls:0.08%
cases:0.66%
controls:0.32%
10
23
1655
16493
—
—
—
—
5
13
1639
16210
10
47
1499
14683
Infected finger/toe
S09 [2002000974]
S09 [2002000974]
—
—
—
—
—
1.3e+00
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.30%
controls:0.08%
cases:0.73%
controls:0.17%
—
—
—
—
—
5
13
1639
16210
11
25
1498
14705
Excision of other lesion extending through all layers of skin in lower limb
QDE10 [2001309980]
QDE10 [2001309980]
—
—
—
1.0e+50
—
—
1.5e+00
—
—
—
—
—
—
cases:0.36%
controls:0.00%
—
—
—
—
cases:0.73%
controls:0.17%
—
—
—
6
0
1659
16516
—
—
11
25
1498
14705
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
26498-6 [3017181]
8.2e-01
6.4e-01
1.6e+00
—
1.3e+00
6.3e-01
6.4e-01
cases:1.38%
controls:0.61%
cases:0.90%
controls:0.48%
cases:0.42%
controls:0.08%
—
—
cases:0.30%
controls:0.08%
cases:1.09%
controls:0.59%
cases:2.92%
controls:1.56%
23
101
1642
16415
15
79
1650
16437
7
14
1658
16502
—
5
13
1660
16482
18
95
1626
16128
44
230
1465
14500
Pain in limb
M79.6 [45587063]
M79.6 [45587063]
1.6e-01
5.5e-01
6.6e-01
—
5.5e-01
5.1e-01
4.0e-01
cases:5.05%
controls:4.34%
cases:3.18%
controls:1.86%
cases:0.42%
controls:0.22%
—
—
cases:0.48%
controls:0.28%
cases:3.41%
controls:2.07%
cases:10.40%
controls:7.23%
84
716
1581
15800
53
308
1612
16208
7
36
1658
16480
—
8
46
1657
16449
56
336
1588
15887
157
1065
1352
13665
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
ACC59 [2001300650]
ACC59 [2001300650]
1.4e+00
1.6e+00
—
—
—
—
4.0e-01
cases:1.02%
controls:0.24%
cases:0.30%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.31%
17
40
1648
16476
5
10
1660
16506
—
—
—
—
7
46
1502
14684
Olecranon bursitis
M70.2 [45557961]
M70.2 [45557961]
1.4e+00
—
—
—
—
1.7e+00
—
cases:0.66%
controls:0.16%
—
—
—
—
—
—
—
—
cases:0.30%
controls:0.06%
—
—
11
26
1654
16490
—
—
—
—
5
9
1639
16214
—
Other and unspecified abdominal pain
R10.4 [45568113]
R10.4 [45568113]
3.9e-01
4.8e-01
—
—
—
6.0e-01
4.4e-01
cases:6.43%
controls:4.44%
cases:2.28%
controls:1.43%
—
—
—
—
—
—
cases:2.49%
controls:1.38%
cases:7.62%
controls:5.06%
107
733
1558
15783
38
236
1627
16280
—
—
—
41
224
1603
15999
115
745
1394
13985
ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]
M01AE03 [21603969]
3.1e-01
1.4e-01
3.8e-01
—
1.4e+00
-2.9e-01
3.7e-01
cases:7.03%
controls:5.26%
cases:1.86%
controls:1.63%
cases:0.30%
controls:0.21%
—
—
cases:0.60%
controls:0.15%
cases:1.09%
controls:1.45%
cases:5.24%
controls:3.67%
117
868
1548
15648
31
269
1634
16247
5
34
1660
16482
—
10
24
1655
16471
18
236
1626
15987
79
540
1430
14190
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
1.6e-01
1.0e-01
4.0e-01
—
9.3e-01
4.9e-01
1.8e-01
cases:8.17%
controls:7.06%
cases:4.08%
controls:3.69%
cases:0.78%
controls:0.53%
—
—
cases:1.14%
controls:0.45%
cases:5.72%
controls:3.59%
cases:13.59%
controls:11.64%
136
1166
1529
15350
68
610
1597
15906
13
87
1652
16429
—
19
75
1646
16420
94
582
1550
15641
205
1714
1304
13016
Care involving use of rehabilitation procedure, unspecified
Z50.9 [45595525]
Z50.9 [45595525]
6.0e-01
—
—
—
—
1.7e+00
1.4e+00
cases:0.54%
controls:0.30%
—
—
—
—
—
—
—
—
cases:0.43%
controls:0.08%
cases:1.33%
controls:0.33%
9
49
1656
16467
—
—
—
—
7
13
1637
16210
20
48
1489
14682
nabumetone; oral
M01AX01 [21603999]
M01AX01 [21603999]
1.1e+00
—
—
—
—
—
1.4e+00
cases:0.60%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
cases:0.66%
controls:0.16%
10
33
1655
16483
—
—
—
—
—
10
24
1499
14706
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
281 [2001600213]
281 [2001600213]
1.4e+00
—
—
—
—
—
1.0e+00
cases:0.90%
controls:0.22%
—
—
—
—
—
—
—
—
—
—
cases:0.60%
controls:0.21%
15
37
1650
16479
—
—
—
—
—
9
31
1500
14699
No procedures
SPAT1301 [2001700402]
SPAT1301 [2001700402]
3.4e-01
6.6e-01
—
-1.0e+50
—
3.6e-01
7.2e-01
cases:5.53%
controls:4.01%
cases:2.94%
controls:1.54%
—
—
cases:0.00%
controls:0.04%
—
—
cases:2.19%
controls:1.53%
cases:9.34%
controls:4.78%
92
662
1573
15854
49
254
1616
16262
—
0
6
1665
16510
—
36
249
1608
15974
141
704
1368
14026
Paranasal sinuses X-ray examination in one projection
DM1QA [2001301761]
DM1QA [2001301761]
9.6e-01
—
—
—
—
—
1.4e+00
cases:0.72%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
cases:0.99%
controls:0.25%
12
46
1653
16470
—
—
—
—
—
15
37
1494
14693
Custom moulded splint, unspecified region
TNX32 [2001308563]
TNX32 [2001308563]
7.9e-01
—
—
—
—
—
1.4e+00
cases:0.78%
controls:0.36%
—
—
—
—
—
—
—
—
—
—
cases:0.99%
controls:0.25%
13
59
1652
16457
—
—
—
—
—
15
37
1494
14693
Lumbago with sciatica
M54.4 [45553205]
M54.4 [45553205]
4.6e-01
8.6e-01
1.7e+00
—
1.5e+00
4.5e-01
5.2e-01
cases:2.58%
controls:1.65%
cases:1.56%
controls:0.67%
cases:0.42%
controls:0.08%
—
—
cases:0.36%
controls:0.08%
cases:1.03%
controls:0.66%
cases:4.17%
controls:2.53%
43
273
1622
16243
26
110
1639
16406
7
13
1658
16503
—
6
13
1659
16482
17
107
1627
16116
63
373
1446
14357
Treatment-related counselling outside office
SPAT1249 [2001700350]
SPAT1249 [2001700350]
2.6e-01
4.6e-01
6.3e-01
—
6.6e-01
5.1e-01
4.0e-01
cases:7.33%
controls:5.72%
cases:3.90%
controls:2.49%
cases:0.78%
controls:0.42%
—
—
cases:0.54%
controls:0.28%
cases:4.14%
controls:2.53%
cases:10.40%
controls:7.22%
122
945
1543
15571
65
411
1600
16105
13
69
1652
16447
—
9
46
1656
16449
68
410
1576
15813
157
1063
1352
13667
Cardiology
6 [38004451]
6 [38004451]
1.7e-01
1.5e-01
-3.9e-01
—
1.0e+00
1.6e-01
3.3e-01
cases:7.93%
controls:6.76%
cases:3.54%
controls:3.06%
cases:0.36%
controls:0.53%
—
—
cases:0.96%
controls:0.35%
cases:3.47%
controls:2.98%
cases:11.33%
controls:8.40%
132
1116
1533
15400
59
505
1606
16011
6
88
1659
16428
—
16
57
1649
16438
57
484
1587
15739
171
1237
1338
13493
Neoplasm of uncertain or unknown behaviour: Skin
D48.5 [45586113]
D48.5 [45586113]
4.0e-01
1.5e+00
—
—
—
8.6e-01
1.3e+00
cases:0.54%
controls:0.36%
cases:0.48%
controls:0.10%
—
—
—
—
—
—
cases:0.30%
controls:0.13%
cases:2.12%
controls:0.57%
9
60
1656
16456
8
17
1657
16499
—
—
—
5
21
1639
16202
32
84
1477
14646
glucosamine; oral
M01AX05 [21604002]
M01AX05 [21604002]
3.6e-01
5.2e-01
6.9e-01
—
6.3e-01
6.7e-01
6.5e-01
cases:4.74%
controls:3.37%
cases:2.10%
controls:1.26%
cases:0.48%
controls:0.24%
—
—
cases:0.42%
controls:0.22%
cases:2.19%
controls:1.13%
cases:6.69%
controls:3.60%
79
556
1586
15960
35
208
1630
16308
8
40
1657
16476
—
7
37
1658
16458
36
183
1608
16040
101
530
1408
14200
Suture or treatment of traumatic wound
SPAT1149 [2001700250]
SPAT1149 [2001700250]
2.3e-01
3.3e-01
—
—
—
1.3e+00
2.0e-01
cases:1.26%
controls:1.01%
cases:0.36%
controls:0.26%
—
—
—
—
—
—
cases:1.03%
controls:0.28%
cases:1.39%
controls:1.14%
21
166
1644
16350
6
43
1659
16473
—
—
—
17
45
1627
16178
21
168
1488
14562
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X69 [45585661]
X69 [45585661]
1.4e-01
—
—
—
—
—
1.3e+00
cases:0.30%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
cases:0.73%
controls:0.20%
5
43
1660
16473
—
—
—
—
—
11
29
1498
14701
Methemoglobin/Hemoglobin.total in Blood
2614-6 [3007930]
2614-6 [3007930]
1.3e+00
—
—
—
—
7.5e-01
4.6e-01
cases:0.84%
controls:0.24%
—
—
—
—
—
—
—
—
cases:0.36%
controls:0.17%
cases:1.06%
controls:0.67%
14
39
1651
16477
—
—
—
—
6
28
1638
16195
16
99
1493
14631
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 [3023081]
20563-3 [3023081]
1.3e+00
—
—
—
—
9.4e-01
3.3e-01
cases:0.84%
controls:0.24%
—
—
—
—
—
—
—
—
cases:0.43%
controls:0.17%
cases:0.99%
controls:0.72%
14
39
1651
16477
—
—
—
—
7
27
1637
16196
15
106
1494
14624
Papillary carcinoma of the thyroid gland (thyroid gland)
C73.91 [2000501197]
C73.91 [2000501197]
9.4e-01
7.2e-01
—
—
—
1.2e+00
1.3e+00
cases:0.66%
controls:0.26%
cases:0.42%
controls:0.21%
—
—
—
—
—
—
cases:0.61%
controls:0.19%
cases:0.80%
controls:0.22%
11
43
1654
16473
7
34
1658
16482
—
—
—
10
31
1634
16192
12
33
1497
14697
carisoprodol; oral
M03BA02 [21604094]
M03BA02 [21604094]
1.3e+00
—
—
—
—
—
8.5e-01
cases:0.90%
controls:0.25%
—
—
—
—
—
—
—
—
—
—
cases:0.33%
controls:0.14%
15
42
1650
16474
—
—
—
—
—
5
21
1504
14709
prednisolone
A07EA01 [21600653]
A07EA01 [21600653]
4.0e-01
3.3e-01
-1.3e-01
—
6.0e-01
4.7e-01
3.9e-01
cases:11.95%
controls:8.36%
cases:4.98%
controls:3.63%
cases:0.54%
controls:0.62%
—
—
cases:1.14%
controls:0.63%
cases:6.02%
controls:3.83%
cases:13.59%
controls:9.59%
199
1380
1466
15136
83
600
1582
15916
9
102
1656
16414
—
19
104
1646
16391
99
622
1545
15601
205
1413
1304
13317
prednisolone; oral, parenteral
H02AB06 [21602734]
H02AB06 [21602734]
4.1e-01
3.2e-01
-1.2e-01
—
6.0e-01
4.7e-01
3.9e-01
cases:11.95%
controls:8.30%
cases:4.92%
controls:3.63%
cases:0.54%
controls:0.61%
—
—
cases:1.14%
controls:0.63%
cases:5.96%
controls:3.82%
cases:13.45%
controls:9.52%
199
1371
1466
15145
82
599
1583
15917
9
101
1656
16415
—
19
104
1646
16391
98
619
1546
15604
203
1403
1306
13327
Low back pain
M54.5 [45553207]
M54.5 [45553207]
3.5e-01
7.3e-01
4.7e-01
—
—
5.1e-01
5.3e-01
cases:5.65%
controls:4.04%
cases:2.88%
controls:1.40%
cases:0.30%
controls:0.19%
—
—
—
—
cases:2.68%
controls:1.63%
cases:10.27%
controls:6.33%
94
667
1571
15849
48
232
1617
16284
5
31
1660
16485
—
—
44
264
1600
15959
155
932
1354
13798
Teaching
WZC30 [2001310891]
WZC30 [2001310891]
2.2e-01
7.2e-01
1.5e+00
1.0e+50
—
1.3e+00
2.9e-01
cases:1.56%
controls:1.26%
cases:1.26%
controls:0.62%
cases:0.48%
controls:0.10%
cases:0.30%
controls:0.00%
—
—
cases:1.46%
controls:0.42%
cases:2.25%
controls:1.70%
26
208
1639
16308
21
102
1644
16414
8
17
1657
16499
5
0
1660
16516
—
24
68
1620
16155
34
250
1475
14480
beclometasone; inhalant
R03BA01 [21603284]
R03BA01 [21603284]
6.5e-01
5.9e-01
4.0e-01
—
—
5.3e-01
5.8e-01
cases:3.54%
controls:1.88%
cases:1.92%
controls:1.07%
cases:0.36%
controls:0.24%
—
—
—
—
cases:1.70%
controls:1.01%
cases:3.18%
controls:1.81%
59
310
1606
16206
32
177
1633
16339
6
40
1659
16476
—
—
28
164
1616
16059
48
267
1461
14463
cetirizine; oral
R06AE07 [21603497]
R06AE07 [21603497]
3.2e-01
2.1e-01
2.3e-01
—
4.8e-01
4.5e-01
4.6e-01
cases:10.21%
controls:7.66%
cases:4.32%
controls:3.54%
cases:0.72%
controls:0.58%
—
—
cases:0.78%
controls:0.48%
cases:5.60%
controls:3.64%
cases:11.27%
controls:7.41%
170
1265
1495
15251
72
584
1593
15932
12
95
1653
16421
—
13
80
1652
16415
92
591
1552
15632
170
1091
1339
13639
Sedation and analgesia
WX002 [2001310758]
WX002 [2001310758]
-4.7e-03
4.8e-01
—
1.0e+50
1.7e+00
1.2e+00
3.9e-01
cases:1.74%
controls:1.75%
cases:0.72%
controls:0.45%
—
—
cases:0.42%
controls:0.00%
cases:0.30%
controls:0.05%
cases:1.40%
controls:0.42%
cases:2.32%
controls:1.59%
29
289
1636
16227
12
74
1653
16442
—
7
0
1658
16516
5
9
1660
16486
23
68
1621
16155
35
234
1474
14496
Corns and callosities
L84 [45533651]
L84 [45533651]
6.6e-01
—
—
—
—
—
1.2e+00
cases:0.48%
controls:0.25%
—
—
—
—
—
—
—
—
—
—
cases:0.86%
controls:0.26%
8
41
1657
16475
—
—
—
—
—
13
38
1496
14692
ispaghula (psylla seeds); oral
A06AC01 [21600555]
A06AC01 [21600555]
1.4e-01
6.1e-01
6.6e-01
—
4.4e-01
5.2e-01
6.0e-01
cases:3.06%
controls:2.68%
cases:2.52%
controls:1.39%
cases:0.48%
controls:0.25%
—
—
cases:0.30%
controls:0.19%
cases:2.25%
controls:1.36%
cases:6.43%
controls:3.63%
51
442
1614
16074
42
229
1623
16287
8
41
1657
16475
—
5
32
1660
16463
37
220
1607
16003
97
535
1412
14195
Own respiration
WX720 [2001310823]
WX720 [2001310823]
8.3e-01
—
—
—
—
1.7e+00
1.2e+00
cases:0.72%
controls:0.31%
—
—
—
—
—
—
—
—
cases:0.36%
controls:0.07%
cases:1.59%
controls:0.48%
12
52
1653
16464
—
—
—
—
6
11
1638
16212
24
71
1485
14659
Cervical spine MRI examination with high intensity magnet
NA1BG [2001306990]
NA1BG [2001306990]
2.3e-01
—
—
—
—
—
1.2e+00
cases:0.54%
controls:0.43%
—
—
—
—
—
—
—
—
—
—
cases:1.39%
controls:0.43%
9
71
1656
16445
—
—
—
—
—
21
63
1488
14667
Urticaria, unspecified
L50.9 [45562541]
L50.9 [45562541]
3.7e-01
-1.0e+50
—
—
—
—
1.2e+00
cases:0.42%
controls:0.29%
cases:0.00%
controls:0.10%
—
—
—
—
—
—
—
—
cases:0.93%
controls:0.29%
7
48
1658
16468
0
16
1665
16500
—
—
—
—
14
42
1495
14688
Inpatient Visit
IP [9201]
IP [9201]
1.8e-01
3.5e-01
—
—
6.4e-01
6.2e-01
5.6e-01
cases:6.79%
controls:5.76%
cases:2.82%
controls:2.01%
—
—
—
—
cases:0.48%
controls:0.25%
cases:3.53%
controls:1.93%
cases:10.60%
controls:6.32%
113
951
1552
15565
47
332
1618
16184
—
—
8
42
1657
16453
58
313
1586
15910
160
931
1349
13799
Rubber band ligature of haemorrhoids or prolapse of mucosa
JHB30 [2001305142]
JHB30 [2001305142]
7.8e-01
—
—
—
—
—
1.2e+00
cases:0.84%
controls:0.39%
—
—
—
—
—
—
—
—
—
—
cases:1.33%
controls:0.41%
14
64
1651
16452
—
—
—
—
—
20
61
1489
14669
Consultation of another employee
SPAT1260 [2001700361]
SPAT1260 [2001700361]
3.6e-01
6.2e-01
—
—
—
1.2e+00
3.9e-01
cases:2.70%
controls:1.90%
cases:1.02%
controls:0.55%
—
—
—
—
—
—
cases:1.82%
controls:0.57%
cases:3.11%
controls:2.12%
45
314
1620
16202
17
91
1648
16425
—
—
—
30
93
1614
16130
47
313
1462
14417
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
30383-4 [3000850]
-6.7e-02
-1.8e-01
—
—
—
6.8e-01
4.9e-01
cases:2.22%
controls:2.37%
cases:0.84%
controls:1.01%
—
—
—
—
—
—
cases:1.95%
controls:1.00%
cases:4.97%
controls:3.12%
37
392
1628
16124
14
166
1651
16350
—
—
—
32
162
1612
16061
75
459
1434
14271
Human epididymis protein 4 [Moles/volume] in Serum or Plasma
55180-4 [40758310]
55180-4 [40758310]
—
—
—
—
—
—
1.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.93%
controls:0.29%
—
—
—
—
—
—
14
43
1495
14687
Acromioplastia, arthroscopic
NBG15 [2001307302]
NBG15 [2001307302]
1.1e+00
1.3e+00
—
—
—
—
7.2e-01
cases:1.56%
controls:0.50%
cases:0.48%
controls:0.13%
—
—
—
—
—
—
—
—
cases:0.93%
controls:0.45%
26
83
1639
16433
8
22
1657
16494
—
—
—
—
14
67
1495
14663
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
890-4 [3001079]
1.3e-01
5.1e-02
2.0e-01
—
9.8e-01
7.8e-01
3.7e-01
cases:6.25%
controls:5.55%
cases:2.58%
controls:2.46%
cases:0.36%
controls:0.30%
—
—
cases:0.66%
controls:0.25%
cases:4.62%
controls:2.18%
cases:10.27%
controls:7.35%
104
917
1561
15599
43
406
1622
16110
6
49
1659
16467
—
11
41
1654
16454
76
354
1568
15869
155
1082
1354
13648
Other spondylosis with radiculopathy
M47.2 [45591850]
M47.2 [45591850]
3.7e-01
9.9e-01
—
—
—
8.3e-01
1.1e+00
cases:0.78%
controls:0.54%
cases:0.60%
controls:0.22%
—
—
—
—
—
—
cases:0.61%
controls:0.27%
cases:1.66%
controls:0.54%
13
89
1652
16427
10
37
1655
16479
—
—
—
10
43
1634
16180
25
79
1484
14651
Ultrasound examination of lower leg veins
PH2AE [2001309451]
PH2AE [2001309451]
5.6e-01
1.1e+00
—
—
—
4.8e-01
6.5e-01
cases:1.44%
controls:0.83%
cases:0.90%
controls:0.29%
—
—
—
—
—
—
cases:0.43%
controls:0.27%
cases:2.05%
controls:1.08%
24
137
1641
16379
15
48
1650
16468
—
—
—
7
43
1637
16180
31
159
1478
14571
Fibromyalgia
M79.7 [45553272]
M79.7 [45553272]
8.7e-01
—
—
—
—
7.6e-01
1.1e+00
cases:0.72%
controls:0.30%
—
—
—
—
—
—
—
—
cases:0.30%
controls:0.14%
cases:1.19%
controls:0.39%
12
50
1653
16466
—
—
—
—
5
23
1639
16200
18
57
1491
14673
Biopsy of skin and subcutaneous tissue
TQX10 [2001310152]
TQX10 [2001310152]
1.2e-01
8.1e-01
—
—
—
1.2e+00
1.1e+00
cases:0.78%
controls:0.69%
cases:0.42%
controls:0.19%
—
—
—
—
—
—
cases:0.55%
controls:0.16%
cases:1.92%
controls:0.64%
13
114
1652
16402
7
31
1658
16485
—
—
—
9
26
1635
16197
29
94
1480
14636
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
313 [2001600274]
313 [2001600274]
1.1e+00
—
—
—
—
1.1e+00
1.2e+00
cases:0.84%
controls:0.28%
—
—
—
—
—
—
—
—
cases:0.30%
controls:0.10%
cases:0.80%
controls:0.24%
14
46
1651
16470
—
—
—
—
5
17
1639
16206
12
36
1497
14694
sumatriptan; nasal, oral, parenteral, rectal
N02CC01 [21604376]
N02CC01 [21604376]
5.0e-01
4.9e-01
2.8e-01
—
5.0e-01
6.0e-01
2.5e-01
cases:4.08%
controls:2.51%
cases:2.04%
controls:1.26%
cases:0.48%
controls:0.36%
—
—
cases:0.48%
controls:0.29%
cases:2.37%
controls:1.32%
cases:3.31%
controls:2.59%
68
415
1597
16101
34
208
1631
16308
8
60
1657
16456
—
8
48
1657
16447
39
214
1605
16009
50
382
1459
14348
Foreign body in skin
S15 [2002000980]
S15 [2002000980]
1.1e+00
1.2e+00
1.0e+50
—
—
1.5e+00
5.9e-01
cases:0.90%
controls:0.30%
cases:0.42%
controls:0.13%
cases:0.30%
controls:0.00%
—
—
—
—
cases:0.43%
controls:0.10%
cases:0.73%
controls:0.41%
15
50
1650
16466
7
22
1658
16494
5
0
1660
16516
—
—
7
16
1637
16207
11
60
1498
14670
Derangement of meniscus due to old tear or injury
M23.2 [45591779]
M23.2 [45591779]
1.1e+00
9.4e-01
—
—
—
2.3e-01
6.5e-01
cases:2.28%
controls:0.78%
cases:0.48%
controls:0.19%
—
—
—
—
—
—
cases:0.36%
controls:0.29%
cases:1.66%
controls:0.87%
38
128
1627
16388
8
31
1657
16485
—
—
—
6
47
1638
16176
25
128
1484
14602
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4537-7 [3013707]
2.4e-01
3.5e-01
5.1e-01
—
2.5e-01
4.1e-01
3.3e-01
cases:14.41%
controls:11.74%
cases:8.59%
controls:6.21%
cases:1.38%
controls:0.84%
—
—
cases:1.20%
controls:0.94%
cases:9.43%
controls:6.44%
cases:23.19%
controls:17.84%
240
1939
1425
14577
143
1025
1522
15491
23
138
1642
16378
—
20
155
1645
16340
155
1045
1489
15178
350
2628
1159
12102
Gastroenterology
10 [38004455]
10 [38004455]
4.9e-01
3.1e-01
-6.7e-02
—
4.5e-01
4.5e-01
6.0e-01
cases:6.19%
controls:3.89%
cases:2.46%
controls:1.81%
cases:0.30%
controls:0.32%
—
—
cases:0.54%
controls:0.35%
cases:2.62%
controls:1.68%
cases:8.35%
controls:4.76%
103
643
1562
15873
41
299
1624
16217
5
53
1660
16463
—
9
57
1656
16438
43
272
1601
15951
126
701
1383
14029
Medical examin/health eval partial
-31 [2002000102]
-31 [2002000102]
5.3e-01
—
—
—
—
—
1.1e+00
cases:0.78%
controls:0.46%
—
—
—
—
—
—
—
—
—
—
cases:1.19%
controls:0.41%
13
76
1652
16440
—
—
—
—
—
18
61
1491
14669
Muscle pain
L18 [2002000642]
L18 [2002000642]
3.5e-01
—
—
—
—
—
1.1e+00
cases:0.30%
controls:0.21%
—
—
—
—
—
—
—
—
—
—
cases:0.99%
controls:0.35%
5
35
1660
16481
—
—
—
—
—
15
51
1494
14679
zolpidem; oral
N05CF02 [21604655]
N05CF02 [21604655]
2.7e-01
1.5e-01
3.5e-01
—
3.6e-01
5.7e-01
4.9e-01
cases:3.66%
controls:2.83%
cases:1.92%
controls:1.67%
cases:0.54%
controls:0.38%
—
—
cases:0.60%
controls:0.42%
cases:2.80%
controls:1.60%
cases:4.90%
controls:3.06%
61
467
1604
16049
32
275
1633
16241
9
63
1656
16453
—
10
69
1655
16426
46
260
1598
15963
74
451
1435
14279
Urology
34 [38004474]
34 [38004474]
4.7e-01
4.3e-01
4.1e-01
—
8.9e-01
5.9e-01
2.9e-01
cases:5.35%
controls:3.42%
cases:2.76%
controls:1.82%
cases:0.48%
controls:0.32%
—
—
cases:0.66%
controls:0.27%
cases:3.16%
controls:1.78%
cases:5.77%
controls:4.39%
89
565
1576
15951
46
300
1619
16216
8
53
1657
16463
—
11
45
1654
16450
52
288
1592
15935
87
647
1422
14083
salbutamol; inhalant
R03AC02 [21603256]
R03AC02 [21603256]
3.0e-01
3.9e-01
2.2e-01
—
6.9e-01
3.2e-01
3.6e-01
cases:15.26%
controls:11.72%
cases:8.05%
controls:5.61%
cases:1.20%
controls:0.97%
—
—
cases:1.74%
controls:0.89%
cases:8.03%
controls:5.95%
cases:19.02%
controls:14.11%
254
1936
1411
14580
134
926
1531
15590
20
160
1645
16356
—
29
146
1636
16349
132
966
1512
15257
287
2079
1222
12651
Cutaneous abscess, furuncle and carbuncle
L02 [45538561]
L02 [45538561]
—
—
—
—
—
—
1.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.99%
controls:0.35%
—
—
—
—
—
—
15
52
1494
14678
Basocellular carcinoma of the skin on another or unspecified part of the face
C44.31 [2000500792]
C44.31 [2000500792]
-1.0e+50
—
-1.0e+50
—
-1.0e+50
7.9e-01
1.0e+00
cases:0.00%
controls:0.26%
—
—
cases:0.00%
controls:0.03%
—
—
cases:0.00%
controls:0.04%
cases:0.36%
controls:0.17%
cases:1.26%
controls:0.45%
0
43
1665
16473
—
0
5
1665
16511
—
0
6
1665
16489
6
27
1638
16196
19
67
1490
14663
Operation for osteochondritis of knee, arthroscopic
NGF25 [2001308133]
NGF25 [2001308133]
1.0e+00
—
—
—
—
—
7.3e-01
cases:0.96%
controls:0.35%
—
—
—
—
—
—
—
—
—
—
cases:0.66%
controls:0.32%
16
58
1649
16458
—
—
—
—
—
10
47
1499
14683
Snapping jaw
K07.60 [2000502791]
K07.60 [2000502791]
1.0e+00
—
—
—
—
9.1e-01
6.7e-01
cases:1.26%
controls:0.47%
—
—
—
—
—
—
—
—
cases:0.43%
controls:0.17%
cases:1.13%
controls:0.58%
21
77
1644
16439
—
—
—
—
7
28
1637
16195
17
85
1492
14645
Skin texture symptom/complaint
S21 [2002000986]
S21 [2002000986]
-6.9e-02
4.2e-01
—
—
—
9.9e-01
2.7e-01
cases:0.96%
controls:1.03%
cases:0.60%
controls:0.39%
—
—
—
—
—
—
cases:0.97%
controls:0.36%
cases:2.12%
controls:1.63%
16
170
1649
16346
10
65
1655
16451
—
—
—
16
59
1628
16164
32
240
1477
14490
Observation for suspected disease or condition, unspecified
Z03.9 [45552062]
Z03.9 [45552062]
4.1e-02
1.5e-01
—
—
1.4e+00
9.8e-01
3.5e-01
cases:2.28%
controls:2.19%
cases:0.90%
controls:0.78%
—
—
—
—
cases:0.30%
controls:0.07%
cases:1.76%
controls:0.67%
cases:3.18%
controls:2.26%
38
362
1627
16154
15
128
1650
16388
—
—
5
12
1660
16483
29
109
1615
16114
48
333
1461
14397
Cardiorespiratory global assessment
SPAT1081 [2001700182]
SPAT1081 [2001700182]
2.0e-01
—
—
—
—
—
9.8e-01
cases:0.48%
controls:0.39%
—
—
—
—
—
—
—
—
—
—
cases:1.13%
controls:0.43%
8
65
1657
16451
—
—
—
—
—
17
63
1492
14667
Eyelid symptom/complaint
F16 [2002000407]
F16 [2002000407]
5.5e-01
—
—
—
—
—
9.6e-01
cases:0.48%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.41%
8
46
1657
16470
—
—
—
—
—
16
60
1493
14670
Foot and toes X-ray examination
NH3AA [2001308267]
NH3AA [2001308267]
6.1e-01
8.4e-01
—
—
—
3.9e-01
9.6e-01
cases:1.02%
controls:0.56%
cases:0.42%
controls:0.18%
—
—
—
—
—
—
cases:0.43%
controls:0.29%
cases:1.92%
controls:0.75%
17
92
1648
16424
7
30
1658
16486
—
—
—
7
47
1637
16176
29
110
1480
14620
Insertion of intrauterine device
TLC00 [2001306647]
TLC00 [2001306647]
9.5e-01
—
—
—
—
—
5.8e-01
cases:1.26%
controls:0.49%
—
—
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.60%
21
81
1644
16435
—
—
—
—
—
16
88
1493
14642
sulfasalazine; oral, rectal
A07EC01 [21600663]
A07EC01 [21600663]
6.3e-01
6.2e-01
—
—
7.4e-02
2.9e-01
9.4e-01
cases:2.04%
controls:1.10%
cases:1.38%
controls:0.75%
—
—
—
—
cases:0.30%
controls:0.28%
cases:0.97%
controls:0.73%
cases:2.45%
controls:0.97%
34
182
1631
16334
23
124
1642
16392
—
—
5
46
1660
16449
16
119
1628
16104
37
143
1472
14587
Pain localized to other parts of lower abdomen
R10.3 [45534426]
R10.3 [45534426]
4.7e-01
-1.9e-01
—
—
—
1.2e-01
4.5e-01
cases:3.72%
controls:2.37%
cases:0.66%
controls:0.80%
—
—
—
—
—
—
cases:0.85%
controls:0.76%
cases:4.71%
controls:3.06%
62
391
1603
16125
11
132
1654
16384
—
—
—
14
123
1630
16100
71
451
1438
14279
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
620-5 [3007853]
4.4e-01
1.8e-01
—
—
—
9.1e-01
3.0e-01
cases:1.98%
controls:1.29%
cases:0.60%
controls:0.50%
—
—
—
—
—
—
cases:1.09%
controls:0.44%
cases:2.65%
controls:1.98%
33
213
1632
16303
10
83
1655
16433
—
—
—
18
72
1626
16151
40
291
1469
14439
Fracture of rib
S22.3 [45573285]
S22.3 [45573285]
4.5e-01
—
-1.0e+50
—
—
—
9.0e-01
cases:0.66%
controls:0.42%
—
—
cases:0.00%
controls:0.03%
—
—
—
—
—
—
cases:1.52%
controls:0.62%
11
70
1654
16446
—
0
5
1665
16511
—
—
—
23
92
1486
14638
lansoprazole; oral
A02BC03 [21600098]
A02BC03 [21600098]
4.6e-01
4.8e-01
1.2e-01
—
6.4e-01
4.4e-01
4.3e-01
cases:7.03%
controls:4.53%
cases:3.42%
controls:2.14%
cases:0.54%
controls:0.48%
—
—
cases:0.72%
controls:0.38%
cases:3.41%
controls:2.21%
cases:6.76%
controls:4.49%
117
749
1548
15767
57
353
1608
16163
9
79
1656
16437
—
12
63
1653
16432
56
359
1588
15864
102
662
1407
14068
Lumbar spine X-ray examination without contrast
NA3AA [2001307026]
NA3AA [2001307026]
3.7e-01
1.2e+00
—
—
—
9.1e-01
8.9e-01
cases:0.84%
controls:0.58%
cases:0.60%
controls:0.18%
—
—
—
—
—
—
cases:0.43%
controls:0.17%
cases:1.72%
controls:0.71%
14
96
1651
16420
10
29
1655
16487
—
—
—
7
28
1637
16195
26
105
1483
14625
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
6.3e-03
1.2e-01
5.6e-01
3.2e-01
3.5e-01
3.3e-01
1.0e-01
cases:20.78%
controls:20.68%
cases:17.24%
controls:15.54%
cases:4.44%
controls:2.60%
cases:0.30%
controls:0.22%
cases:3.72%
controls:2.64%
cases:21.41%
controls:16.32%
cases:36.25%
controls:33.96%
346
3415
1319
13101
287
2567
1378
13949
74
429
1591
16087
5
36
1660
16480
62
436
1603
16059
352
2648
1292
13575
547
5003
962
9727
Lumbar spine MRI examination with high intensity magnet
NA3BG [2001307034]
NA3BG [2001307034]
6.7e-01
1.1e+00
—
—
—
8.8e-01
8.9e-01
cases:1.26%
controls:0.65%
cases:0.66%
controls:0.22%
—
—
—
—
—
—
cases:0.55%
controls:0.23%
cases:2.12%
controls:0.88%
21
107
1644
16409
11
36
1654
16480
—
—
—
9
37
1635
16186
32
130
1477
14600
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
1.0e-02
1.3e-01
5.6e-01
3.5e-01
3.6e-01
3.2e-01
1.0e-01
cases:21.08%
controls:20.91%
cases:17.60%
controls:15.76%
cases:4.56%
controls:2.65%
cases:0.30%
controls:0.21%
cases:3.78%
controls:2.68%
cases:21.53%
controls:16.55%
cases:36.58%
controls:34.24%
351
3453
1314
13063
293
2603
1372
13913
76
438
1589
16078
5
35
1660
16481
63
442
1602
16053
354
2685
1290
13538
552
5044
957
9686
HLA-B27 [Presence]
4821-5 [3008898]
4821-5 [3008898]
8.7e-02
—
—
—
—
—
8.9e-01
cases:0.60%
controls:0.55%
—
—
—
—
—
—
—
—
—
—
cases:1.33%
controls:0.55%
10
91
1655
16425
—
—
—
—
—
20
81
1489
14649
Polyarthrosis, unspecified
M15.9 [45543481]
M15.9 [45543481]
3.3e-02
—
—
—
—
—
8.9e-01
cases:0.30%
controls:0.29%
—
—
—
—
—
—
—
—
—
—
cases:1.26%
controls:0.52%
5
48
1660
16468
—
—
—
—
—
19
77
1490
14653
Body CT examination
JN4AD [2001310897]
JN4AD [2001310897]
—
—
—
—
—
5.6e-01
8.9e-01
—
—
—
—
—
—
—
—
—
—
cases:0.49%
controls:0.28%
cases:1.92%
controls:0.80%
—
—
—
—
—
8
45
1636
16178
29
118
1480
14612
Specific gravity of Urine by Refractometry
5810-7 [3019150]
5810-7 [3019150]
3.2e-01
5.4e-01
1.2e+00
—
—
5.3e-01
3.6e-01
cases:4.08%
controls:3.01%
cases:2.64%
controls:1.56%
cases:0.54%
controls:0.16%
—
—
—
—
cases:3.16%
controls:1.89%
cases:8.35%
controls:5.98%
68
497
1597
16019
44
257
1621
16259
9
27
1656
16489
—
—
52
307
1592
15916
126
881
1383
13849
metronidazole; oral, rectal
P01AB01 [21604857]
P01AB01 [21604857]
3.3e-01
4.8e-01
3.5e-01
—
9.8e-01
4.0e-01
5.5e-01
cases:8.83%
controls:6.51%
cases:2.76%
controls:1.73%
cases:0.36%
controls:0.25%
—
—
cases:0.42%
controls:0.16%
cases:2.62%
controls:1.77%
cases:10.34%
controls:6.25%
147
1075
1518
15441
46
285
1619
16231
6
42
1659
16474
—
7
26
1658
16469
43
287
1601
15936
156
920
1353
13810
Back syndrome with radiating pain
L86 [2002000705]
L86 [2002000705]
-2.4e-01
—
—
—
—
6.4e-01
8.8e-01
cases:0.30%
controls:0.38%
—
—
—
—
—
—
—
—
cases:0.30%
controls:0.16%
cases:1.33%
controls:0.56%
5
63
1660
16453
—
—
—
—
5
26
1639
16197
20
82
1489
14648
Dorsalgia, unspecified
M54.9 [45538791]
M54.9 [45538791]
-1.1e-01
5.0e-01
-1.0e+50
—
-1.0e+50
9.2e-02
8.7e-01
cases:0.84%
controls:0.94%
cases:0.48%
controls:0.29%
cases:0.00%
controls:0.05%
—
—
cases:0.00%
controls:0.04%
cases:0.30%
controls:0.28%
cases:2.72%
controls:1.16%
14
155
1651
16361
8
48
1657
16468
0
8
1665
16508
—
0
7
1665
16488
5
45
1639
16178
41
171
1468
14559
Cancer Ag 125 [Units/volume] in Serum or Plasma
10334-1 [3037551]
10334-1 [3037551]
3.2e-01
1.8e-01
-1.0e+50
—
—
—
8.7e-01
cases:0.78%
controls:0.57%
cases:0.42%
controls:0.35%
cases:0.00%
controls:0.07%
—
—
—
—
—
—
cases:1.79%
controls:0.76%
13
94
1652
16422
7
58
1658
16458
0
12
1665
16504
—
—
—
27
112
1482
14618
Extractable nuclear Ab [Units/volume] in Serum
30342-0 [3015171]
30342-0 [3015171]
1.4e-01
6.5e-01
—
—
—
—
8.6e-01
cases:0.60%
controls:0.52%
cases:0.36%
controls:0.19%
—
—
—
—
—
—
—
—
cases:1.52%
controls:0.65%
10
86
1655
16430
6
31
1659
16485
—
—
—
—
23
96
1486
14634
Dysphagia
R13 [45573013]
R13 [45573013]
5.3e-01
—
—
—
—
—
8.5e-01
cases:0.90%
controls:0.53%
—
—
—
—
—
—
—
—
—
—
cases:1.39%
controls:0.60%
15
88
1650
16428
—
—
—
—
—
21
88
1488
14642
Ear microscopy
UDC00 [2001301558]
UDC00 [2001301558]
8.3e-01
6.3e-01
—
—
—
5.0e-01
3.8e-01
cases:1.38%
controls:0.61%
cases:0.42%
controls:0.22%
—
—
—
—
—
—
cases:0.36%
controls:0.22%
cases:0.86%
controls:0.59%
23
100
1642
16416
7
37
1658
16479
—
—
—
6
36
1638
16187
13
87
1496
14643
Mouth breathing
R06.5 [45573006]
R06.5 [45573006]
8.3e-01
2.7e-01
-1.0e+50
—
—
1.3e+00
7.5e-01
cases:1.50%
controls:0.66%
cases:0.30%
controls:0.23%
cases:0.00%
controls:0.03%
—
—
—
—
cases:0.55%
controls:0.15%
cases:1.33%
controls:0.63%
25
109
1640
16407
5
38
1660
16478
0
5
1665
16511
—
—
9
24
1635
16199
20
93
1489
14637
Partial excision of meniscus of knee, arthroscopic
NGD05 [2001308109]
NGD05 [2001308109]
8.3e-01
1.1e+00
—
—
—
9.1e-01
5.0e-01
cases:1.92%
controls:0.85%
cases:0.54%
controls:0.18%
—
—
—
—
—
—
cases:0.36%
controls:0.15%
cases:1.33%
controls:0.81%
32
140
1633
16376
9
30
1656
16486
—
—
—
6
24
1638
16199
20
119
1489
14611
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
1.8e-01
6.0e-02
7.1e-01
—
5.0e-01
4.9e-01
3.4e-01
cases:6.07%
controls:5.12%
cases:3.18%
controls:3.00%
cases:0.72%
controls:0.36%
—
—
cases:0.78%
controls:0.47%
cases:4.20%
controls:2.63%
cases:11.20%
controls:8.21%
101
845
1564
15671
53
496
1612
16020
12
59
1653
16457
—
13
78
1652
16417
69
426
1575
15797
169
1210
1340
13520
Migraine, unspecified
G43.9 [45595943]
G43.9 [45595943]
8.3e-01
6.0e-01
—
—
-1.0e+50
5.0e-01
-5.1e-01
cases:1.44%
controls:0.64%
cases:0.42%
controls:0.23%
—
—
—
—
cases:0.00%
controls:0.04%
cases:0.30%
controls:0.18%
cases:0.46%
controls:0.77%
24
105
1641
16411
7
38
1658
16478
—
—
0
6
1665
16489
5
30
1639
16193
7
113
1502
14617
oxycodone; oral, parenteral
N02AA05 [21604260]
N02AA05 [21604260]
8.2e-01
4.0e-01
—
—
9.1e-01
1.4e-01
3.0e-01
cases:1.62%
controls:0.72%
cases:0.72%
controls:0.48%
—
—
—
—
cases:0.36%
controls:0.15%
cases:0.79%
controls:0.69%
cases:1.99%
controls:1.49%
27
119
1638
16397
12
80
1653
16436
—
—
6
24
1659
16471
13
112
1631
16111
30
219
1479
14511
valaciclovir; oral
J05AB11 [21603137]
J05AB11 [21603137]
1.6e-01
3.3e-01
9.5e-01
—
—
8.2e-01
4.5e-01
cases:1.86%
controls:1.60%
cases:0.96%
controls:0.69%
cases:0.36%
controls:0.14%
—
—
—
—
cases:1.58%
controls:0.70%
cases:3.18%
controls:2.06%
31
264
1634
16252
16
114
1649
16402
6
23
1659
16493
—
—
26
114
1618
16109
48
303
1461
14427
Wrist symptom/complaint
L11 [2002000635]
L11 [2002000635]
8.2e-01
6.9e-01
—
—
—
3.2e-01
2.8e-01
cases:1.44%
controls:0.64%
cases:0.42%
controls:0.21%
—
—
—
—
—
—
cases:0.30%
controls:0.22%
cases:1.33%
controls:1.00%
24
106
1641
16410
7
35
1658
16481
—
—
—
5
36
1639
16187
20
148
1489
14582
Application of soft bandage
SPAT1211 [2001700312]
SPAT1211 [2001700312]
5.2e-01
9.7e-01
—
—
2.0e+00
5.9e-01
8.1e-01
cases:1.08%
controls:0.65%
cases:0.54%
controls:0.21%
—
—
—
—
cases:0.30%
controls:0.04%
cases:0.36%
controls:0.20%
cases:1.52%
controls:0.69%
18
107
1647
16409
9
34
1656
16482
—
—
5
7
1660
16488
6
33
1638
16190
23
101
1486
14629
Cervicalgia
M54.2 [45591867]
M54.2 [45591867]
4.0e-01
4.8e-01
—
—
—
1.1e+00
8.1e-01
cases:0.84%
controls:0.56%
cases:0.36%
controls:0.22%
—
—
—
—
—
—
cases:0.67%
controls:0.22%
cases:1.66%
controls:0.75%
14
93
1651
16423
6
37
1659
16479
—
—
—
11
36
1633
16187
25
110
1484
14620
Upper gastrointestinal surgery
106 [44777669]
106 [44777669]
3.8e-01
1.7e-01
3.6e-01
—
4.3e-01
4.5e-01
4.2e-01
cases:9.73%
controls:6.88%
cases:3.12%
controls:2.65%
cases:0.60%
controls:0.42%
—
—
cases:0.54%
controls:0.35%
cases:3.95%
controls:2.55%
cases:11.27%
controls:7.68%
162
1137
1503
15379
52
438
1613
16078
10
69
1655
16447
—
9
58
1656
16437
65
414
1579
15809
170
1132
1339
13598
Hallux valgus (acquired)
M20.1 [45606152]
M20.1 [45606152]
7.9e-01
1.2e+00
—
—
—
5.8e-01
6.7e-01
cases:1.38%
controls:0.63%
cases:0.66%
controls:0.21%
—
—
—
—
—
—
cases:0.55%
controls:0.31%
cases:1.39%
controls:0.72%
23
104
1642
16412
11
34
1654
16482
—
—
—
9
50
1635
16173
21
106
1488
14624
Cells panel - Urine sediment
58434-2 [40761535]
58434-2 [40761535]
3.0e-01
5.5e-01
—
—
—
8.4e-01
7.9e-01
cases:1.26%
controls:0.94%
cases:0.78%
controls:0.45%
—
—
—
—
—
—
cases:0.85%
controls:0.37%
cases:3.05%
controls:1.41%
21
155
1644
16361
13
75
1652
16441
—
—
—
14
60
1630
16163
46
207
1463
14523
triamcinolone; nasal
R01AD11 [21605052]
R01AD11 [21605052]
7.9e-01
5.0e-01
-1.0e+50
—
—
5.3e-01
5.7e-01
cases:1.56%
controls:0.71%
cases:0.48%
controls:0.29%
cases:0.00%
controls:0.05%
—
—
—
—
cases:0.61%
controls:0.36%
cases:1.19%
controls:0.68%
26
118
1639
16398
8
48
1657
16468
0
9
1665
16507
—
—
10
58
1634
16165
18
100
1491
14630
Arthritis, unspecified
M13.9 [45567463]
M13.9 [45567463]
3.2e-01
9.8e-01
—
—
-1.0e+50
7.8e-01
7.9e-01
cases:0.78%
controls:0.57%
cases:0.66%
controls:0.25%
—
—
—
—
cases:0.00%
controls:0.04%
cases:0.55%
controls:0.25%
cases:1.52%
controls:0.70%
13
94
1652
16422
11
41
1654
16475
—
—
0
6
1665
16489
9
41
1635
16182
23
103
1486
14627
Gas panel - Arterial blood
24336-0 [3019060]
24336-0 [3019060]
6.5e-01
—
—
—
-1.0e+50
5.7e-01
7.7e-01
cases:0.84%
controls:0.44%
—
—
—
—
—
—
cases:0.00%
controls:0.04%
cases:0.43%
controls:0.24%
cases:1.72%
controls:0.81%
14
73
1651
16443
—
—
—
0
7
1665
16488
7
39
1637
16184
26
119
1483
14611
Hypersensitivity skin testing
268377001 [4147813]
268377001 [4147813]
7.7e-01
9.1e-01
—
—
—
—
5.3e-01
cases:1.74%
controls:0.82%
cases:0.60%
controls:0.24%
—
—
—
—
—
—
—
—
cases:1.19%
controls:0.71%
29
135
1636
16381
10
40
1655
16476
—
—
—
—
18
104
1491
14626
fluconazole; oral, parenteral
J02AC01 [21603080]
J02AC01 [21603080]
3.5e-01
4.6e-01
1.5e-01
—
6.6e-01
3.0e-01
4.1e-01
cases:9.49%
controls:6.90%
cases:3.48%
controls:2.23%
cases:0.36%
controls:0.31%
—
—
cases:0.48%
controls:0.25%
cases:2.92%
controls:2.19%
cases:8.68%
controls:5.92%
158
1139
1507
15377
58
369
1607
16147
6
51
1659
16465
—
8
41
1657
16454
48
355
1596
15868
131
872
1378
13858
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
8.7e-02
1.3e-01
4.8e-01
7.3e-01
1.7e-01
2.7e-01
1.0e-01
cases:27.63%
controls:25.92%
cases:24.26%
controls:21.92%
cases:7.09%
controls:4.49%
cases:0.60%
controls:0.29%
cases:5.29%
controls:4.51%
cases:27.80%
controls:22.64%
cases:44.07%
controls:41.52%
460
4281
1205
12235
404
3620
1261
12896
118
741
1547
15775
10
48
1655
16468
88
744
1577
15751
457
3673
1187
12550
665
6116
844
8614
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
8.8e-02
1.3e-01
4.8e-01
7.5e-01
1.8e-01
2.7e-01
1.1e-01
cases:27.51%
controls:25.79%
cases:24.20%
controls:21.85%
cases:7.03%
controls:4.46%
cases:0.60%
controls:0.28%
cases:5.35%
controls:4.50%
cases:27.62%
controls:22.55%
cases:44.07%
controls:41.47%
458
4260
1207
12256
403
3608
1262
12908
117
736
1548
15780
10
47
1655
16469
89
742
1576
15753
454
3658
1190
12565
665
6109
844
8621
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
8.9e-02
1.3e-01
4.8e-01
7.5e-01
1.8e-01
2.7e-01
1.0e-01
cases:27.57%
controls:25.84%
cases:24.26%
controls:21.88%
cases:7.03%
controls:4.46%
cases:0.60%
controls:0.28%
cases:5.35%
controls:4.50%
cases:27.68%
controls:22.59%
cases:44.00%
controls:41.47%
459
4267
1206
12249
404
3613
1261
12903
117
737
1548
15779
10
47
1655
16469
89
742
1576
15753
455
3664
1189
12559
664
6108
845
8622
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
8.8e-02
1.3e-01
4.8e-01
7.5e-01
1.8e-01
2.7e-01
1.0e-01
cases:27.57%
controls:25.85%
cases:24.26%
controls:21.89%
cases:7.03%
controls:4.46%
cases:0.60%
controls:0.28%
cases:5.35%
controls:4.50%
cases:27.68%
controls:22.61%
cases:44.00%
controls:41.49%
459
4269
1206
12247
404
3615
1261
12901
117
737
1548
15779
10
47
1655
16469
89
742
1576
15753
455
3668
1189
12555
664
6112
845
8618
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
6.4e-02
1.6e-01
4.6e-01
4.0e-01
3.4e-01
2.9e-01
1.3e-01
cases:24.14%
controls:23.00%
cases:21.08%
controls:18.60%
cases:5.53%
controls:3.56%
cases:0.36%
controls:0.24%
cases:4.86%
controls:3.53%
cases:24.64%
controls:19.68%
cases:40.89%
controls:37.71%
402
3798
1263
12718
351
3072
1314
13444
92
588
1573
15928
6
40
1659
16476
81
582
1584
15913
405
3193
1239
13030
617
5555
892
9175
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
8.6e-02
1.3e-01
4.7e-01
7.5e-01
1.8e-01
2.7e-01
1.1e-01
cases:27.45%
controls:25.78%
cases:24.08%
controls:21.83%
cases:6.97%
controls:4.45%
cases:0.60%
controls:0.28%
cases:5.35%
controls:4.49%
cases:27.62%
controls:22.53%
cases:44.00%
controls:41.41%
457
4257
1208
12259
401
3606
1264
12910
116
735
1549
15781
10
47
1655
16469
89
741
1576
15754
454
3655
1190
12568
664
6100
845
8630
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
9.1e-02
1.3e-01
4.8e-01
7.5e-01
1.8e-01
2.6e-01
1.1e-01
cases:27.63%
controls:25.85%
cases:24.20%
controls:21.88%
cases:7.03%
controls:4.47%
cases:0.60%
controls:0.28%
cases:5.35%
controls:4.50%
cases:27.55%
controls:22.60%
cases:44.07%
controls:41.48%
460
4269
1205
12247
403
3613
1262
12903
117
738
1548
15778
10
47
1655
16469
89
743
1576
15752
453
3666
1191
12557
665
6110
844
8620
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
N02AE01 [21604287]
7.4e-01
5.9e-01
—
—
1.5e+00
2.8e-01
1.4e-01
cases:1.80%
controls:0.87%
cases:0.78%
controls:0.44%
—
—
—
—
cases:0.48%
controls:0.11%
cases:0.73%
controls:0.55%
cases:1.72%
controls:1.51%
30
143
1635
16373
13
72
1652
16444
—
—
8
18
1657
16477
12
90
1632
16133
26
222
1483
14508
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
2465-3 [3005719]
2.0e-01
5.7e-02
—
—
—
4.6e-01
7.4e-01
cases:1.14%
controls:0.93%
cases:0.48%
controls:0.45%
—
—
—
—
—
—
cases:0.67%
controls:0.43%
cases:2.65%
controls:1.28%
19
154
1646
16362
8
75
1657
16441
—
—
—
11
69
1633
16154
40
189
1469
14541
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
8.2e-02
1.3e-01
4.7e-01
7.5e-01
1.8e-01
2.7e-01
1.0e-01
cases:27.51%
controls:25.90%
cases:24.32%
controls:21.94%
cases:6.97%
controls:4.48%
cases:0.60%
controls:0.28%
cases:5.35%
controls:4.50%
cases:27.68%
controls:22.66%
cases:44.07%
controls:41.50%
458
4277
1207
12239
405
3624
1260
12892
116
740
1549
15776
10
47
1655
16469
89
742
1576
15753
455
3676
1189
12547
665
6113
844
8617
ABO and Rh group [Type] in Blood
882-1 [3003694]
882-1 [3003694]
8.1e-02
3.8e-02
—
—
—
7.3e-01
1.1e-01
cases:3.42%
controls:3.17%
cases:1.20%
controls:1.16%
—
—
—
—
—
—
cases:2.01%
controls:0.98%
cases:4.51%
controls:4.06%
57
523
1608
15993
20
191
1645
16325
—
—
—
33
159
1611
16064
68
598
1441
14132
Gastro-oesophageal reflux disease without oesophagitis
K21.9 [45538509]
K21.9 [45538509]
7.2e-01
3.9e-01
—
—
—
4.1e-01
3.7e-01
cases:1.68%
controls:0.83%
cases:0.42%
controls:0.28%
—
—
—
—
—
—
cases:0.43%
controls:0.28%
cases:1.59%
controls:1.10%
28
137
1637
16379
7
47
1658
16469
—
—
—
7
46
1637
16177
24
162
1485
14568
Cervicobrachial syndrome
M53.1 [45567577]
M53.1 [45567577]
6.7e-01
3.8e-01
—
—
—
5.0e-01
7.1e-01
cases:1.68%
controls:0.87%
cases:0.54%
controls:0.37%
—
—
—
—
—
—
cases:0.85%
controls:0.52%
cases:2.85%
controls:1.42%
28
143
1637
16373
9
61
1656
16455
—
—
—
14
84
1630
16139
43
209
1466
14521
Headache
R51.80 [2000503603]
R51.80 [2000503603]
4.9e-01
8.1e-01
—
—
—
5.9e-01
7.1e-01
cases:2.40%
controls:1.48%
cases:0.96%
controls:0.43%
—
—
—
—
—
—
cases:0.85%
controls:0.47%
cases:3.11%
controls:1.56%
40
245
1625
16271
16
71
1649
16445
—
—
—
14
77
1630
16146
47
230
1462
14500
pseudoephedrine, combinations; oral
R01BA52 [21603213]
R01BA52 [21603213]
1.8e-01
4.1e-01
8.6e-01
—
-3.8e-02
3.6e-01
2.8e-01
cases:11.59%
controls:9.83%
cases:4.86%
controls:3.28%
cases:0.78%
controls:0.33%
—
—
cases:0.42%
controls:0.44%
cases:4.87%
controls:3.45%
cases:12.72%
controls:9.93%
193
1624
1472
14892
81
541
1584
15975
13
55
1652
16461
—
7
72
1658
16423
80
559
1564
15664
192
1463
1317
13267
Other specified intervertebral disc degeneration
M51.3 [45591865]
M51.3 [45591865]
2.9e-01
4.2e-01
—
—
—
3.9e-01
6.8e-01
cases:1.14%
controls:0.86%
cases:0.48%
controls:0.31%
—
—
—
—
—
—
cases:0.43%
controls:0.29%
cases:2.05%
controls:1.05%
19
142
1646
16374
8
52
1657
16464
—
—
—
7
47
1637
16176
31
155
1478
14575
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
1960-4 [3008152]
8.5e-01
—
—
—
—
8.8e-01
6.8e-01
cases:0.96%
controls:0.41%
—
—
—
—
—
—
—
—
cases:0.61%
controls:0.25%
cases:2.05%
controls:1.05%
16
68
1649
16448
—
—
—
—
10
41
1634
16182
31
155
1478
14575
Naevus/mole
S82 [2002001046]
S82 [2002001046]
3.0e-01
3.1e-01
—
—
-1.0e+50
3.3e-01
6.8e-01
cases:1.38%
controls:1.02%
cases:0.42%
controls:0.31%
—
—
—
—
cases:0.00%
controls:0.04%
cases:0.49%
controls:0.35%
cases:2.85%
controls:1.47%
23
169
1642
16347
7
51
1658
16465
—
—
0
6
1665
16489
8
57
1636
16166
43
216
1466
14514
fluticasone; nasal
R01AD08 [21605050]
R01AD08 [21605050]
3.2e-01
3.8e-01
2.0e-01
—
1.5e-01
3.8e-01
3.5e-01
cases:11.23%
controls:8.43%
cases:5.05%
controls:3.52%
cases:0.72%
controls:0.59%
—
—
cases:0.84%
controls:0.72%
cases:4.99%
controls:3.46%
cases:12.26%
controls:8.93%
187
1393
1478
15123
84
581
1581
15935
12
98
1653
16418
—
14
119
1651
16376
82
562
1562
15661
185
1316
1324
13414
fluticasone furoate; nasal
R01AD12 [21605053]
R01AD12 [21605053]
3.2e-01
3.8e-01
2.0e-01
—
1.5e-01
3.8e-01
3.5e-01
cases:11.23%
controls:8.43%
cases:5.05%
controls:3.52%
cases:0.72%
controls:0.59%
—
—
cases:0.84%
controls:0.72%
cases:4.99%
controls:3.46%
cases:12.26%
controls:8.93%
187
1393
1478
15123
84
581
1581
15935
12
98
1653
16418
—
14
119
1651
16376
82
562
1562
15661
185
1316
1324
13414
celecoxib
L01XX33 [21603805]
L01XX33 [21603805]
4.2e-01
6.1e-01
—
—
—
7.4e-01
6.7e-01
cases:2.76%
controls:1.83%
cases:1.02%
controls:0.56%
—
—
—
—
—
—
cases:0.91%
controls:0.44%
cases:3.18%
controls:1.66%
46
302
1619
16214
17
92
1648
16424
—
—
—
15
71
1629
16152
48
244
1461
14486
celecoxib; oral
M01AH01 [21603992]
M01AH01 [21603992]
4.2e-01
6.1e-01
—
—
—
7.4e-01
6.7e-01
cases:2.76%
controls:1.83%
cases:1.02%
controls:0.56%
—
—
—
—
—
—
cases:0.91%
controls:0.44%
cases:3.18%
controls:1.66%
46
302
1619
16214
17
92
1648
16424
—
—
—
15
71
1629
16152
48
244
1461
14486
Low back symptom/complaint
L03 [2002000628]
L03 [2002000628]
2.7e-01
6.6e-01
—
—
—
2.1e-01
3.8e-01
cases:3.54%
controls:2.72%
cases:1.92%
controls:1.01%
—
—
—
—
—
—
cases:1.40%
controls:1.14%
cases:5.63%
controls:3.93%
59
450
1606
16066
32
166
1633
16350
—
—
—
23
185
1621
16038
85
579
1424
14151
pantoprazole; oral, parenteral
A02BC02 [21600097]
A02BC02 [21600097]
1.7e-01
1.7e-01
1.7e-01
-1.0e+50
-9.5e-03
3.0e-01
3.4e-01
cases:15.74%
controls:13.60%
cases:8.65%
controls:7.42%
cases:1.68%
controls:1.43%
cases:0.00%
controls:0.03%
cases:1.50%
controls:1.52%
cases:9.91%
controls:7.53%
cases:22.27%
controls:16.92%
262
2246
1403
14270
144
1226
1521
15290
28
236
1637
16280
0
5
1665
16511
25
250
1640
16245
163
1221
1481
15002
336
2493
1173
12237
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
UJD10 [2001304788]
3.8e-01
9.2e-02
—
—
—
3.1e-01
6.4e-01
cases:4.50%
controls:3.13%
cases:1.02%
controls:0.93%
—
—
—
—
—
—
cases:1.28%
controls:0.94%
cases:6.30%
controls:3.41%
75
517
1590
15999
17
154
1648
16362
—
—
—
21
153
1623
16070
95
503
1414
14227
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
551
3794
1.65
19.71
4.5
4.0
1.02
1.41
kg/l
0.50
366
2539
185
987
1.97
15.48
7.9
7.7
24.48
24.53
mmol/l
0.07
180
948
82
323
2.61
14.22
5.9
10.1
11.16
11.31
mmol/l
0.15
76
295
82
323
2.61
14.22
5.9
10.1
105.39
105.39
mmol/l
0.01
76
295
895
7255
1.46
13.76
4.8
5.2
36.28
35.91
g/l
1.24
842
6832
895
7303
1.44
13.01
13.5
13.6
1.20
1.22
inr
0.69
772
6071
816
6550
1.44
12.94
4.2
3.7
0.16
0.12
estimate
0.10
179
1499
1366
12118
1.50
12.46
5.4
4.4
11.32
11.76
mm/h
0.58
1281
11407
429
3073
1.52
11.97
1.4
1.3
17.04
11.52
u/ml
0.69
196
1211
194
1167
1.74
11.02
3.1
2.9
133.51
189.00
ng/l
1.81
187
1060
125
656
1.97
10.96
5.5
6.6
0.91
0.88
%
0.32
119
618
211
1329
1.66
10.10
2.5
2.7
64.83
68.24
ml/min/173m2
0.71
95
574
910
7658
1.37
10.02
2.8
2.8
—
—
estimate
—
0
0
130
715
1.88
9.92
5.3
6.2
1.97
1.57
%
2.25
124
678
1090
9548
1.35
8.73
5.0
5.3
6.58
6.66
mmol/l
0.67
1036
9071
1002
8674
1.34
8.64
4.4
3.9
0.00
5.98
estimate
2.07
218
1837
1005
8735
1.33
8.28
4.4
3.9
0.00
0.19
estimate
0.54
210
1718
646
5275
1.35
8.10
2.8
2.7
56.39
75.77
u/l
0.69
606
4919
1751
16821
1.93
7.83
21.8
20.1
75.97
75.85
umol/l
0.06
1742
16664
1692
16100
1.67
7.78
18.9
18.1
139.84
139.70
mmol/l
1.63
1670
15829
1695
16137
1.67
7.76
19.0
18.3
3.97
3.96
mmol/l
0.38
1671
15837
433
3338
1.39
7.76
1.4
1.3
38.54
29.85
iu/ml
0.61
152
1039
230
1577
1.52
7.65
6.6
10.1
122.48
121.53
g/l
0.28
225
1545
1665
15801
1.59
7.49
17.0
15.7
21.45
23.23
mg/l
1.42
1407
13049
405
3108
1.39
7.42
3.7
3.8
307.08
471.43
ng/l
0.54
286
2344
979
8575
1.30
7.17
4.3
3.8
0.01
0.00
estimate
0.73
217
1792
248
1758
1.47
7.01
8.2
6.8
—
—
—
0
0
37
141
2.66
6.99
1.5
1.5
26.38
31.56
%
0.33
13
86
579
4733
1.33
6.98
4.9
4.0
0.00
0.01
estimate
1.74
209
1693
263
1895
1.45
6.83
6.4
9.0
5.06
5.10
kpa
0.24
257
1834
263
1895
1.45
6.83
6.4
9.0
12.53
12.41
kpa
0.12
257
1834
613
5070
1.31
6.75
2.2
2.2
178.89
208.61
u/l
0.55
584
4834
237
1686
1.47
6.57
6.3
9.6
96.32
95.67
%
1.16
229
1635
257
1872
1.43
6.28
6.3
9.1
1.28
0.97
mmol/l
0.67
209
1552
531
4352
1.31
6.13
2.8
2.7
337.39
338.07
umol/l
0.06
470
3868
1438
13399
1.34
6.09
18.9
19.2
13.59
13.60
%
0.13
1424
13233
447
3609
1.32
5.70
2.7
2.7
5.67
5.84
e6/l
0.09
417
3297
1146
10431
1.26
5.40
4.9
4.6
177.28
1692.79
e6/l
2.08
18
149
1586
15086
1.38
5.23
6.4
6.2
38.68
39.12
mmol/mol
1.55
1513
14234
340
4235
0.76
4.99
3.5
4.1
91.54
91.60
%
0.02
327
4143
132
1922
0.66
4.95
5.1
4.9
32.65
32.25
%
0.17
96
1319
970
8731
1.24
4.76
6.2
6.7
10.86
11.18
umol/l
0.42
925
8373
1769
17240
1.76
4.73
26.1
23.9
135.97
135.57
g/l
0.60
1761
17089
912
8167
1.23
4.65
7.2
7.5
1.21
1.21
mmol/l
0.02
787
7108
1767
17228
1.72
4.53
26.0
23.8
256.20
253.39
e9/l
1.16
1755
16939
1767
17233
1.71
4.46
25.8
23.7
90.84
91.04
fl
1.07
1759
17085
1767
17235
1.71
4.43
25.9
23.8
4.51
4.50
e12/l
0.55
1752
16901
1767
17235
1.71
4.43
26.2
24.3
40.63
40.46
%
0.75
1759
17076
1767
17238
1.71
4.39
26.0
23.8
6.62
6.70
e9/l
0.82
1751
16900
7
256
0.27
4.29
8.0
6.5
382.29
359.05
umol/l
—
7
235
104
691
1.54
4.07
1.3
1.2
0.94
0.99
u/ml
—
7
46
1336
12543
1.24
4.02
9.0
8.4
77.20
78.13
u/l
0.25
1290
11976
1554
14858
1.30
3.97
5.8
5.5
1.83
1.88
mu/l
0.65
1475
13887
1663
16067
1.38
3.87
6.1
5.8
2.73
2.76
mmol/l
0.57
1587
15088
1646
15880
1.36
3.84
5.5
5.1
4.66
4.70
mmol/l
1.02
1577
14972
364
3001
1.27
3.81
1.5
1.5
—
—
—
0
0
200
2588
0.74
3.77
3.2
3.0
4.21
2.60
e6/l
0.73
100
1250
1720
16726
1.46
3.75
13.5
12.2
26.79
26.40
u/l
0.36
1691
16342
696
6160
1.21
3.73
3.7
3.6
23.77
63.22
ng/l
2.39
435
4189
91
600
1.54
3.71
1.6
1.5
—
—
—
0
0
242
1903
1.31
3.66
2.0
1.8
—
—
—
0
0
1030
9470
1.20
3.63
9.7
10.0
4.04
4.06
e9/l
0.12
939
8297
1594
15344
1.30
3.49
5.3
5.1
5.85
5.91
mmol/l
1.05
1509
14225
549
4774
1.21
3.48
3.3
3.3
0.06
0.24
estimate
0.48
182
1444
1346
12715
1.22
3.48
4.9
4.5
14.77
14.72
pmol/l
0.39
1276
11808
613
5403
1.20
3.35
4.1
4.2
7.33
8.63
mg/mmol
0.40
363
3344
249
1991
1.29
3.33
1.9
1.8
—
—
—
0
0
174
1326
1.34
3.28
2.5
2.5
0.30
0.45
e6/l
0.71
165
1266
807
7323
1.18
3.12
6.6
6.8
1.21
1.21
mmol/l
0.11
753
6805
70
457
1.55
3.04
1.6
1.4
—
—
—
0
0
22
100
2.21
3.00
5.7
6.9
9.59
188.00
ug/l
0.54
12
64
21
94
2.25
2.97
1.2
1.1
—
—
—
0
0
69
455
1.54
2.88
1.5
1.6
—
—
—
0
0
388
3319
1.21
2.85
1.6
1.7
26543623.88
37580963.19
pmol/l
0.16
324
2794
780
7105
1.17
2.78
2.1
1.9
1.40
1.38
mmol/l
0.26
681
6075
92
651
1.44
2.74
2.1
2.0
1.90
1.86
ug/l
0.02
84
586
1629
15809
1.27
2.72
5.3
5.0
1.45
1.48
mmol/l
1.70
1553
14804
632
5669
1.18
2.72
3.4
3.4
7.87
7.52
mmol/l
1.04
542
4852
41
241
1.72
2.71
1.6
1.7
—
—
—
0
0
314
2650
1.22
2.64
2.0
1.9
—
—
—
0
0
645
5807
1.17
2.63
3.3
3.3
33.48
31.99
u/l
0.27
615
5510
15
333
0.45
2.62
1.3
1.5
—
—
—
0
0
827
7594
1.16
2.61
2.7
2.5
77.66
77.45
nmol/l
0.08
767
6938
65
434
1.52
2.59
1.9
1.6
8080.55
11174.04
e6/l
0.47
47
303
22
107
2.07
2.57
2.7
2.2
—
—
—
0
0
65
436
1.51
2.54
1.5
1.6
—
—
—
0
0
65
436
1.51
2.54
5.6
4.0
3.94
3.85
mmol/l
0.72
65
431
1092
10260
1.16
2.48
3.1
3.0
—
—
—
0
0
855
7897
1.16
2.44
3.4
3.1
111.23
121.32
ug/l
0.84
814
7428
29
159
1.84
2.44
4.6
5.2
30.69
40.55
u/ml
—
10
49
66
449
1.49
2.43
1.1
1.1
23.20
5.13
eliau/ml
—
8
59
140
1086
1.31
2.39
3.6
3.5
4.46
4.50
pmol/l
0.22
130
965
16
334
0.47
2.39
1.3
1.5
0.78
1.21
ratio
—
9
209
16
334
0.47
2.39
1.3
1.5
1.09
1.14
ratio
—
9
209
16
334
0.47
2.39
1.3
1.5
0.99
0.98
ratio
—
9
209
29
163
1.79
2.27
1.4
1.3
3686.53
105097.90
e6/l
1.52
17
108
18
349
0.51
2.19
1.4
1.5
50.25
59.07
ug/l
0.58
13
288
318
2737
1.20
2.18
1.5
1.5
—
—
—
0
0
511
4575
1.16
2.18
1.7
1.7
20.43
20.56
nmol/l
0.08
442
3889
475
4232
1.17
2.16
2.5
2.3
2.60
2.81
mg/l
1.49
432
3672
26
444
0.58
2.07
3.0
3.3
2.94
2.24
index
0.25
16
242
16
316
0.50
2.07
2.6
3.0
7.28
7.42
mmol/l
0.09
16
305
15
302
0.49
2.06
1.4
1.3
—
—
—
0
0
15
302
0.49
2.06
1.4
1.3
—
—
—
0
0
368
3229
1.17
2.02
2.5
3.0
2.45
2.45
mmol/l
0.03
337
2912
159
1287
1.26
1.99
1.4
1.5
—
—
—
0
0
50
338
1.49
1.95
1.5
1.4
—
—
—
0
0
67
915
0.72
1.88
2.9
3.5
1.75
1.83
mmol/l
0.09
51
682
32
197
1.64
1.87
1.3
1.5
69.56
56.34
ug/l
0.97
32
197
626
5746
1.14
1.83
3.4
3.6
2.35
2.35
mmol/l
0.06
583
5254
56
394
1.43
1.81
1.5
1.5
—
—
—
0
0
513
4655
1.14
1.78
3.0
3.1
1063.05
1107.76
ng/l
0.10
458
3956
115
914
1.28
1.71
1.3
1.4
22.86
29.63
iu/l
1.90
108
783
438
3946
1.14
1.68
1.4
1.3
1.73
1.50
u/ml
0.15
148
1102
144
1178
1.24
1.68
1.5
1.7
—
—
—
0
0
18
97
1.86
1.66
1.7
1.7
89.67
103.19
ng/l
0.44
18
97
20
112
1.79
1.64
1.6
1.4
82.00
78.76
umol/l
0.15
20
112
83
1069
0.77
1.60
3.1
3.6
5.17
5.16
kpa
0.05
83
1033
7
26
2.70
1.58
6.4
8.5
10.27
10.52
%
—
7
26
195
1657
1.20
1.57
3.0
3.2
—
—
—
0
0
400
3600
1.14
1.56
4.8
4.2
21.86
21.50
%
0.18
193
1622
69
520
1.34
1.53
2.9
2.2
5237.35
4856.13
u/l
0.04
24
217
131
1075
1.24
1.51
1.3
1.3
48.65
46.40
au/ml
0.04
11
79
15
79
1.91
1.49
1.0
1.3
234.07
408.42
u/l
0.64
15
73
12
59
2.04
1.43
1.0
1.4
—
—
—
0
0
29
188
1.55
1.43
1.2
1.2
—
—
—
0
0
11
53
2.08
1.38
1.6
1.4
10.43
9.20
ug/l
0.69
11
53
40
281
1.43
1.36
1.8
1.6
—
—
—
0
0
311
2783
1.14
1.33
2.7
3.5
0.83
0.82
mmol/l
0.57
302
2647
12
61
1.97
1.33
1.6
1.5
—
—
—
0
0
30
201
1.50
1.30
1.2
1.4
—
—
—
0
0
32
459
0.69
1.27
2.8
2.6
0.00
0.00
g/l
-0.00
32
430
32
219
1.47
1.26
1.4
1.6
—
—
—
0
0
484
4464
1.11
1.26
5.5
5.2
2.10
2.26
ug/l
0.39
450
4045
18
108
1.67
1.22
2.6
1.8
17.43
8.40
ug/l
0.51
18
93
138
1169
1.20
1.20
2.4
2.5
29.23
22.15
au/ml
0.34
17
128
17
101
1.69
1.20
2.7
2.4
578.92
582.02
e6/l
0.01
12
87
281
2517
1.14
1.19
1.6
2.1
29.31
29.46
s
0.16
270
2451
59
455
1.31
1.17
1.3
1.3
—
—
—
0
0
26
381
0.68
1.17
2.2
2.9
1.58
1.56
mmol/l
0.04
26
367
1539
15073
1.13
1.17
4.5
4.3
1.32
1.30
mmol/l
0.43
1468
14011
45
597
0.75
1.14
2.5
2.7
1.66
1.19
g/l
0.20
40
520
59
754
0.78
1.14
1.3
1.7
0.24
0.33
mg/l
0.98
23
366
38
275
1.39
1.14
1.5
1.5
—
—
—
0
0
158
1364
1.17
1.12
3.3
2.9
9.99
10.70
g/l
1.24
144
1259
69
548
1.27
1.11
3.4
2.7
—
—
—
0
0
48
627
0.76
1.10
2.9
3.5
45.92
2431.12
u/ml
0.89
37
546
38
277
1.38
1.10
1.4
1.6
—
—
—
0
0
249
2229
1.14
1.08
4.9
6.1
1.02
1.03
mmol/l
0.19
229
2064
17
105
1.62
1.06
2.8
2.4
230.92
234.34
e6/l
0.04
12
95
370
4016
0.90
1.03
2.3
2.4
—
—
—
0
0
21
138
1.53
1.03
1.2
1.5
1.55
1.13
promille
0.55
15
111
7
34
2.06
1.03
6.4
7.6
5.50
5.15
kpa
—
7
34
244
2193
1.13
1.00
2.8
2.5
143.48
121.66
ug/g
0.37
203
1774
18
274
0.65
1.00
1.1
1.2
2.67
4.79
u/ml
—
6
117
147
1279
1.16
0.97
2.3
2.3
4.78
7.91
ug/l
2.50
138
1152
0
30
0.00
0.97
0.0
2.6
—
7.24
—
0
16
148
1289
1.16
0.97
3.9
3.8
91.50
86.61
ng/l
0.26
134
1127
0
31
0.00
0.96
0.0
2.3
—
9070.00
—
0
5
54
678
0.79
0.94
2.4
2.5
3.92
3.69
g/l
0.25
49
626
6
116
0.52
0.94
1.0
1.5
—
—
—
0
0
54
427
1.27
0.93
1.3
1.2
34.54
52.55
u/ml
—
5
42
16
101
1.59
0.93
1.5
1.2
0.54
0.52
ratio
—
9
60
8
142
0.56
0.93
1.4
1.1
—
36.33
—
0
6
303
2777
1.11
0.90
2.7
2.6
13.12
13.40
umol/l
0.27
284
2588
191
2135
0.88
0.90
1.7
1.9
1.37
1.45
%
1.00
171
1876
183
1630
1.14
0.89
1.9
2.3
0.21
0.22
g/l
0.33
159
1526
94
798
1.19
0.86
2.5
1.9
—
—
—
0
0
33
247
1.34
0.85
1.1
1.1
6.09
2.15
eliau/ml
0.98
17
112
10
167
0.60
0.85
1.4
1.1
—
49.80
—
0
10
41
318
1.30
0.84
2.0
2.1
4.63
5.14
mmol/24h
0.56
36
282
31
231
1.35
0.83
1.2
1.1
—
—
—
0
0
82
966
0.84
0.80
1.6
1.7
—
—
—
0
0
124
1086
1.15
0.79
7.5
11.1
93.83
93.94
%
0.07
124
1078
42
331
1.28
0.78
1.5
1.5
—
—
—
0
0
0
28
0.00
0.76
0.0
1.7
—
1.39
—
0
15
61
732
0.83
0.74
1.4
2.0
1.45
1.57
g/l
0.55
55
646
7
38
1.85
0.73
1.1
1.0
—
—
—
0
0
106
926
1.15
0.71
3.2
3.5
193.90
66.84
u/ml
0.49
101
897
94
814
1.16
0.71
1.3
1.4
—
—
—
0
0
10
157
0.63
0.69
1.2
1.2
—
—
—
0
0
61
511
1.20
0.68
1.3
1.3
—
—
—
0
0
7
43
1.63
0.67
1.1
1.3
—
—
—
0
0
14
94
1.49
0.66
1.4
1.4
176.26
157.17
pmol/l
0.27
14
94
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
94
0.53
0.66
1.4
1.1
—
—
—
0
0
5
28
1.79
0.66
1.0
1.1
89.92
66.57
ug/l
—
5
23
1160
11331
1.06
0.64
3.4
3.4
47.51
46.97
u/l
0.08
1103
10736
5
29
1.73
0.64
1.0
1.1
85.20
98.52
%
—
5
29
43
523
0.82
0.62
2.3
1.8
—
—
—
0
0
0
20
0.00
0.60
0.0
8.1
—
6.16
—
0
20
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
11
163
0.67
0.60
2.9
3.6
—
—
—
0
0
31
245
1.27
0.59
1.2
1.3
25.49
27.37
u/l
0.12
26
203
91
800
1.14
0.59
3.5
3.7
49.67
48.00
%
0.26
91
783
31
388
0.80
0.59
1.3
1.6
—
—
—
0
0
11
72
1.53
0.59
2.5
2.5
35.38
50.76
umol/l
1.34
11
63
0
23
0.00
0.58
0.0
1.5
—
—
—
0
0
64
550
1.17
0.56
1.7
1.5
32.03
0.18
iu/ml
—
10
89
121
1088
1.12
0.56
7.6
10.9
1.43
1.30
%
1.06
121
1079
5
89
0.56
0.56
1.2
1.3
—
—
—
0
0
11
160
0.69
0.55
1.5
1.2
—
—
—
0
0
13
182
0.71
0.54
3.2
2.1
2.04
0.44
mmol/l
1.14
13
177
42
501
0.83
0.52
2.2
2.1
2.71
15.70
iu/l
0.58
17
201
12
83
1.45
0.51
1.8
1.8
—
—
—
0
0
12
83
1.45
0.51
1.8
1.8
—
—
—
0
0
12
83
1.45
0.51
1.8
1.8
—
—
—
0
0
12
83
1.45
0.51
1.8
1.8
—
—
—
0
0
203
1885
1.09
0.51
4.7
4.4
247.68
246.85
u/l
0.03
194
1793
149
1365
1.10
0.51
2.2
3.0
68.99
70.87
e9/l
0.30
116
1005
48
563
0.85
0.50
2.2
2.7
24.95
24.78
mmol/l
0.13
48
557
275
2589
1.07
0.49
2.7
2.5
2.43
2.32
g/l
2.63
256
2401
7
46
1.52
0.48
1.0
1.2
—
—
—
0
0
150
1629
0.91
0.48
2.2
2.5
122.41
69.19
u/l
0.24
129
1394
7
47
1.49
0.47
1.3
1.2
—
—
—
0
0
95
1055
0.90
0.47
6.1
9.1
25.31
24.96
mmol/l
0.38
95
1049
14
188
0.74
0.47
1.7
1.5
—
—
—
0
0
20
155
1.29
0.46
1.1
1.3
—
—
titre
—
0
0
21
164
1.28
0.46
1.7
1.8
—
—
—
0
0
108
979
1.11
0.46
2.6
2.0
—
—
—
0
0
119
1087
1.10
0.44
2.0
1.9
1.29
1.38
g/l
0.17
109
1009
10
69
1.45
0.44
1.6
2.5
32.04
135.99
ug/l
—
10
59
265
2802
0.94
0.44
2.9
2.9
1.32
1.04
e6/l
0.69
161
1468
31
372
0.83
0.43
1.5
1.4
—
20.62
—
0
8
43
368
1.17
0.43
2.2
2.4
114.88
121.35
ug/min
0.04
25
224
177
1651
1.08
0.42
2.1
2.2
369.74
374.47
nmol/l
0.13
159
1540
6
92
0.65
0.42
1.0
1.1
—
—
—
0
0
52
453
1.15
0.42
1.1
1.2
—
—
—
0
0
52
454
1.15
0.41
1.1
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
5.6
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
33
277
1.19
0.41
1.2
1.1
—
1.32
—
0
14
14
105
1.34
0.41
1.3
1.3
143.93
137.30
nmol/l
0.16
14
105
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
58
656
0.88
0.40
1.2
1.8
6.63
5.01
mg/l
0.20
46
489
29
347
0.83
0.40
1.2
1.2
252.58
257.69
u/ml
0.04
19
204
27
223
1.21
0.39
1.1
1.3
0.16
0.26
nmol/l
0.62
19
176
22
270
0.81
0.39
1.1
1.1
—
—
—
0
0
51
580
0.88
0.39
2.2
2.0
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
28.03
—
0
12
9
66
1.37
0.38
4.0
4.4
—
—
—
0
0
9
66
1.37
0.38
1.6
1.0
—
—
—
0
0
44
504
0.87
0.37
1.8
1.4
309.31
285.93
ug/g
0.30
26
306
9
68
1.33
0.37
1.2
1.3
139.56
137.05
nmol/l
—
9
52
5
37
1.35
0.37
1.2
1.2
0.24
130.64
mg/l
—
5
27
17
134
1.27
0.37
1.6
1.7
—
—
—
0
0
81
735
1.11
0.36
1.9
2.0
9.20
8.33
iu/ml
0.10
22
175
541
5245
1.04
0.36
3.5
3.4
48.17
64.30
e6/l
0.37
452
4000
31
264
1.18
0.34
1.2
1.3
—
0.40
nmol/l
—
0
18
11
145
0.76
0.34
2.2
2.7
—
—
—
0
0
394
3798
1.05
0.34
1.6
1.7
0.92
1.14
mg/l
1.14
314
2925
84
767
1.10
0.34
2.3
2.1
39.45
40.06
u/l
0.11
78
693
22
181
1.22
0.34
1.8
1.7
—
—
—
0
0
60
539
1.12
0.33
1.4
1.3
234.97
219.33
miu/ml
0.10
23
256
6
87
0.69
0.33
1.2
1.1
—
—
—
0
0
113
1050
1.08
0.32
7.5
11.2
0.71
0.65
%
0.93
113
1043
58
523
1.11
0.31
1.7
1.9
41.38
38.97
nmol/l
0.31
58
506
78
850
0.91
0.31
1.0
1.1
—
—
—
0
0
91
840
1.09
0.31
1.4
1.5
—
—
—
0
0
249
2381
1.05
0.31
2.7
2.6
22.16
23.20
%
0.62
232
2217
54
485
1.12
0.31
1.2
1.3
—
—
—
0
0
137
1458
0.93
0.30
1.7
1.8
3.44
3.52
mmol/l
0.41
84
1031
13
164
0.79
0.30
1.3
1.1
—
—
—
0
0
7
99
0.71
0.30
1.1
1.1
—
—
—
0
0
12
153
0.78
0.30
1.2
1.0
—
—
—
0
0
48
536
0.89
0.30
1.2
1.3
—
—
—
0
0
61
553
1.11
0.30
4.7
4.0
41.93
56.61
mg/l
0.57
56
477
24
204
1.18
0.28
1.9
1.6
50.74
30.62
ng/l
0.38
24
204
15
121
1.24
0.28
1.3
1.1
—
—
—
0
0
132
1244
1.07
0.27
1.3
1.2
109.95
137.20
u/ml
0.43
52
485
53
584
0.90
0.27
1.5
1.6
988.34
1005.74
mu/l
0.05
43
472
8
66
1.21
0.26
1.4
2.0
50.66
48.08
ug/l
—
8
66
8
66
1.21
0.26
1.0
1.3
—
—
—
0
0
24
278
0.86
0.26
1.1
1.2
1.44
3.30
u/ml
—
9
89
11
138
0.80
0.25
1.3
1.1
106.82
108.83
pmol/l
0.04
11
138
6
82
0.73
0.24
1.3
1.2
—
—
—
0
0
6
83
0.72
0.24
1.2
1.6
—
—
—
0
0
6
83
0.72
0.24
1.2
1.6
—
—
—
0
0
1543
15333
1.04
0.24
14.6
15.0
81.97
82.31
ml/min/173m2
0.29
1467
14233
56
514
1.09
0.23
1.4
1.2
1.76
2.48
u/ml
—
5
46
12
147
0.82
0.23
1.3
1.2
0.21
0.66
u/ml
—
6
74
11
136
0.81
0.23
1.4
1.1
—
—
—
0
0
34
304
1.12
0.22
1.6
1.8
—
—
—
0
0
7
95
0.74
0.22
3.1
3.7
0.71
0.84
index
—
7
95
7
95
0.74
0.22
3.3
3.0
449.29
1186.09
u/ml
—
7
95
10
79
1.27
0.22
1.2
1.4
122.10
172.57
mmol/24h
—
10
79
30
267
1.13
0.21
2.8
3.3
0.75
0.82
nmol/l
0.45
25
221
129
1355
0.95
0.21
3.0
2.9
4.54
4.54
kpa
0.01
129
1314
56
517
1.09
0.21
1.4
1.2
3.58
10.69
u/ml
—
9
78
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
67
624
1.08
0.21
1.5
1.5
—
—
—
0
0
5
43
1.16
0.21
1.0
1.2
195.20
320.37
pmol/l
—
5
30
0
13
0.00
0.21
0.0
1.2
—
20.30
—
0
6
10
80
1.25
0.20
1.4
1.9
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
70
655
1.07
0.20
1.1
1.1
0.75
0.67
ratio
0.49
11
76
15
127
1.18
0.19
1.5
1.2
—
—
—
0
0
17
146
1.17
0.19
1.6
1.6
—
—
—
0
0
16
137
1.17
0.18
1.3
1.4
7.93
9.00
mmol/l
0.77
16
132
30
332
0.90
0.18
1.5
1.4
146.60
152.78
au/ml
—
5
93
15
128
1.17
0.18
1.5
1.2
—
—
—
0
0
90
853
1.06
0.18
3.2
2.5
0.67
0.62
%
0.90
90
848
14
119
1.18
0.17
1.1
1.7
—
—
—
0
0
11
91
1.21
0.17
1.1
1.4
—
73.09
%
—
0
11
29
320
0.90
0.17
1.2
1.1
10.30
16.43
au/ml
—
7
82
264
2712
0.97
0.17
3.2
3.1
0.74
0.75
ug/l
0.03
154
1661
44
407
1.08
0.17
1.4
1.4
15.03
36.02
e6/l
0.56
37
297
33
301
1.10
0.17
1.0
1.1
0.40
1.82
u/ml
1.52
12
129
36
392
0.92
0.17
1.5
1.5
—
—
—
0
0
5
69
0.72
0.17
2.6
1.9
—
—
—
0
0
5
69
0.72
0.17
2.6
1.9
—
—
—
0
0
5
70
0.71
0.16
2.6
1.9
—
—
—
0
0
12
141
0.85
0.16
1.3
1.1
—
—
—
0
0
12
141
0.85
0.16
1.3
1.1
—
—
—
0
0
460
4518
1.02
0.16
3.2
3.2
0.61
0.43
e6/l
0.57
370
3302
8
73
1.10
0.15
1.0
1.2
537.38
226.27
iu/ml
—
8
73
8
73
1.10
0.15
1.0
1.1
—
—
—
0
0
24
216
1.11
0.15
1.4
1.7
—
—
—
0
0
19
169
1.13
0.14
1.0
1.1
—
—
—
0
0
61
645
0.94
0.14
1.7
1.6
24.89
12.69
u/ml
0.62
17
142
44
411
1.07
0.14
1.5
1.4
981.24
1086.27
e6/l
0.06
37
318
34
314
1.08
0.14
1.0
1.1
4.35
3.91
u/ml
0.09
15
167
338
3446
0.98
0.14
1.6
1.5
2.31
2.43
g/l
0.68
234
2186
74
705
1.05
0.13
1.1
1.1
1.51
1.54
g/l
0.50
74
705
12
103
1.17
0.13
1.2
1.1
1.09
1.09
u/l
—
7
53
8
98
0.82
0.13
1.3
1.1
—
—
—
0
0
38
355
1.07
0.12
1.0
1.1
0.36
1.98
u/ml
3.04
16
194
12
137
0.88
0.12
1.3
1.1
—
—
—
0
0
10
116
0.86
0.12
1.4
1.2
—
—
—
0
0
162
1663
0.97
0.11
3.8
4.4
56.68
17.75
ug/l
0.35
138
1349
21
192
1.09
0.10
1.4
1.4
—
—
—
0
0
21
192
1.09
0.10
1.4
1.4
—
—
—
0
0
37
349
1.06
0.10
1.5
1.6
—
—
—
0
0
190
1940
0.98
0.10
2.7
2.9
7.15
7.57
umol/l
0.16
167
1725
21
193
1.09
0.10
1.4
1.4
—
—
—
0
0
45
473
0.95
0.09
1.9
1.7
—
—
—
0
0
27
289
0.93
0.09
1.0
1.1
2.45
1.50
u/ml
0.19
11
145
5
47
1.06
0.09
1.2
1.1
—
—
—
0
0
134
1374
0.97
0.09
2.9
3.0
67.40
66.77
g/l
0.47
129
1275
5
48
1.04
0.09
1.6
1.1
—
—
—
0
0
6
54
1.11
0.09
1.2
1.1
—
—
—
0
0
16
146
1.10
0.08
1.7
1.6
—
—
—
0
0
16
146
1.10
0.08
1.7
1.6
—
—
—
0
0
16
146
1.10
0.08
1.7
1.6
—
—
—
0
0
20
185
1.08
0.08
1.5
1.6
—
—
—
0
0
5
65
0.77
0.08
1.0
1.1
—
—
—
0
0
7
64
1.09
0.08
1.3
1.9
37.70
41.05
g/l
—
7
64
14
154
0.91
0.08
1.0
1.1
324.44
285.63
mg/l
—
9
139
258
2544
1.02
0.07
1.8
1.7
1329.39
1189.61
nmol/l
1.82
211
1954
19
176
1.08
0.07
1.7
1.3
1767.36
1931.80
e6/l
0.09
14
110
8
78
1.03
0.07
1.9
3.1
2.00
1.35
%
—
8
78
37
353
1.05
0.07
1.1
2.1
1.00
0.89
nmol/l
0.58
31
302
19
204
0.93
0.07
1.1
1.1
—
—
—
0
0
8
94
0.85
0.06
1.4
1.2
7.38
9.89
mm/h
—
8
94
21
197
1.07
0.06
1.6
1.4
—
—
—
0
0
11
121
0.91
0.06
1.7
1.5
—
—
—
0
0
34
326
1.04
0.05
2.0
2.6
16.94
16.27
%
0.75
34
320
10
90
1.11
0.05
1.0
1.4
—
—
—
0
0
33
344
0.96
0.05
1.6
1.4
—
—
—
0
0
21
222
0.95
0.05
1.0
1.0
0.01
0.34
u/ml
—
5
74
31
323
0.96
0.05
3.0
3.9
32.04
24.73
mg/l
0.45
21
224
157
1549
1.01
0.05
2.0
1.9
—
—
—
0
0
28
292
0.96
0.04
1.7
1.3
—
—
—
0
0
31
298
1.04
0.04
2.4
2.7
1123.00
1624.11
u/ml
—
5
19
21
221
0.95
0.04
1.5
2.1
—
2022.86
—
0
7
30
312
0.96
0.04
1.4
1.2
13.02
33.71
u/l
2.12
25
268
168
1700
0.99
0.04
2.0
2.0
—
—
—
0
0
10
91
1.10
0.04
1.0
1.4
—
—
—
0
0
38
392
0.97
0.04
2.0
2.2
132.97
129.49
g/l
0.43
33
313
53
543
0.98
0.04
2.2
3.2
1.42
1.50
mg/l
0.47
46
498
21
200
1.05
0.03
1.6
1.4
—
—
—
0
0
12
129
0.93
0.03
1.7
1.4
—
—
—
0
0
12
129
0.93
0.03
1.2
1.2
—
88.20
—
0
5
710
7123
0.99
0.03
2.2
2.1
95.18
96.91
pmol/l
0.53
368
3787
11
118
0.93
0.02
2.5
2.3
818.33
614.63
ml
—
6
79
14
148
0.95
0.02
1.3
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
50
490
1.02
0.02
2.3
2.8
0.31
0.36
iu/ml
0.64
32
257
49
481
1.02
0.02
1.4
1.4
6.91
9.90
u/l
1.64
44
389
126
1271
0.99
0.02
4.9
3.9
1.24
1.23
mmol/l
1.33
107
1100
10
107
0.93
0.02
1.7
1.7
—
—
—
0
0
193
1941
0.99
0.01
2.0
2.0
3.75
3.48
ratio
2.01
140
1517
94
949
0.99
0.01
3.7
3.5
24.17
24.25
mmol/l
0.09
94
940
47
463
1.02
0.01
1.0
1.3
—
—
—
0
0
49
497
0.99
0.01
3.8
3.7
2.97
3.80
ratio
0.21
34
286
11
104
1.06
0.01
1.9
2.5
7.08
8.69
mmol/l
1.41
11
104
11
105
1.05
0.00
1.7
1.6
—
—
—
0
0
12
115
1.04
0.00
1.0
1.1
—
9.54
—
0
36
15
155
0.97
0.00
1.7
1.3
38474.87
111333.09
e6/l
—
8
75
11
109
1.01
0.00
1.7
1.6
—
—
—
0
0
60
599
1.00
0.00
1.8
1.7
—
—
—
0
0
24
244
0.98
0.00
1.7
1.8
1.47
1.66
mmol/l
0.69
24
238
39
394
0.99
0.00
1.9
2.7
8.21
8.13
kpa
0.12
39
387
158
1576
1.00
0.00
3.7
3.5
1.67
1.88
mmol/l
0.29
138
1360
130
1302
1.00
0.00
2.4
2.4
13.47
13.19
nmol/l
0.16
120
1188
11
107
1.03
0.00
1.5
1.4
4.91
7.86
u/l
1.02
11
90
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
306.00
—
0
5
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
9.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
30
300
1.00
-0.00
1.3
1.2
—
51.43
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
33
330
1.00
-0.00
5.1
4.2
4.90
5.07
kpa
0.51
33
325
9
96
0.94
-0.00
1.6
1.1
850.67
1615.99
miu/ml
—
9
96
0
8
0.00
-0.00
0.0
1.0
—
0.00
—
0
8
0
7
0.00
-0.00
0.0
1.0
—
1.45
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
58
0.86
-0.00
2.0
2.5
0.65
0.61
mmol/l
—
5
58
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
7.91
—
0
8
6
67
0.90
-0.00
1.2
1.1
—
—
—
0
0
5
55
0.91
-0.00
1.0
1.3
—
—
—
0
0
102
1020
1.00
-0.00
2.7
3.0
124.91
129.90
g/l
1.34
96
994
20
200
1.00
-0.00
1.6
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
5
49
1.02
-0.00
1.6
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_CONNSOFT_UPPERLIMB and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_CONNSOFT_UPPERLIMB | 0.94 [0.82, 1.08] | 0.387 |
| Birth year | 0.99 [0.98, 1.0] | 0.028 |
During the follow-up period (1.1.1998 — 31.12.2019), 318 out of 4348 females with CD2_BENIGN_CONNSOFT_UPPERLIMB died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_CONNSOFT_UPPERLIMB | 0.861 [0.75, 0.99] | 0.039 |
| Birth year | 0.99 [0.98, 1.0] | 0.028 |
During the follow-up period (1.1.1998 — 31.12.2019), 344 out of 3643 males with CD2_BENIGN_CONNSOFT_UPPERLIMB died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_CONNSOFT_UPPERLIMB.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.063% | 0.184% |
| 5 | 0.461% | 1.067% |
| 10 | 1.17% | 2.703% |
| 15 | 2.402% | 5.095% |
| 20 | 4.083% | 8.63% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_CONNSOFT_UPPERLIMB – Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder
GWS hits: 3
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data